Carbon	carbon	NN	O
dioxide	dioxide	NN	O
CO2	CO2	NNP	O
is	be	VBZ	O
a	a	DT	O
product	product	NN	O
of	of	IN	O
many	many	JJ	O
metabolic	metabolic	JJ	O
aerobic	aerobic	JJ	O
processes	process	NNS	O
in	in	IN	O
different	different	JJ	O
organisms	organism	NNS	O
.	.	.	O

It	-PRON-	PRP	O
has	have	VBZ	O
a	a	DT	O
relatively	relatively	RB	O
low	low	JJ	O
solubility	solubility	NN	O
in	in	IN	O
water	water	NN	O
,	,	,	O
but	but	CC	O
it	-PRON-	PRP	O
reacts	react	VBZ	O
with	with	IN	O
this	this	DT	O
solvent	solvent	NN	O
at	at	IN	O
the	the	DT	O
neutral	neutral	JJ	O
pH	pH	NNP	O
to	to	TO	O
produce	produce	VB	O
bicarbonate	bicarbonate	JJ	O
anion	anion	NN	O
and	and	CC	O
protons	proton	NNS	O
.	.	.	O

These	these	DT	O
two	two	CD	O
ions	ion	NNS	O
play	play	VBP	O
a	a	DT	O
crucial	crucial	JJ	O
role	role	NN	O
in	in	IN	O
maintaining	maintain	VBG	O
pH	pH	NNP	O
homeostasis	homeostasis	NN	O
in	in	IN	O
living	living	NN	O
systems	system	NNS	O
and	and	CC	O
their	-PRON-	PRP$	O
equilibration	equilibration	NN	O
with	with	IN	O
CO2	CO2	NNP	O
is	be	VBZ	O
controlled	control	VBN	O
by	by	IN	O
the	the	DT	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
enzymes	enzyme	NNS	O
Carbonic	Carbonic	NNP	O
Anhydrase	Anhydrase	NNP	O
CA	CA	NNP	O
,	,	,	O
EC	EC	NNP	O
4.2.1.1	4.2.1.1	CD	O
)	)	-RRB-	B
.	.	.	O

CAs	ca	NNS	O
are	be	VBP	O
extremely	extremely	RB	O
efficient	efficient	JJ	O
catalysts	catalyst	NNS	O
,	,	,	O
and	and	CC	O
they	-PRON-	PRP	O
are	be	VBP	O
widespread	widespread	JJ	O
in	in	IN	O
organisms	organism	NNS	O
all	all	RB	O
over	over	IN	O
the	the	DT	O
phylogenetic	phylogenetic	JJ	O
tree	tree	NN	O
.	.	.	O

So	so	RB	O
far	far	RB	O
,	,	,	O
there	there	EX	O
are	be	VBP	O
eight	eight	CD	O
genetically	genetically	RB	O
distinct	distinct	JJ	O
families	family	NNS	O
categorised	categorise	VBN	O
as	as	IN	O
Î±-	Î±-	NNP	O
,	,	,	O
Î²-	î²-	UH	O
,	,	,	O
Î³-	î³-	UH	O
,	,	,	O
Î´-	Î´-	NNP	O
,	,	,	O
Î¶-	î¶-	CD	O
,	,	,	O
Î·-	Î·-	NNP	O
,	,	,	O
Î-	î-	UH	O
and	and	CC	O
â-CAs	â-cas	JJ	B
.	.	.	O

In	in	IN	O
mammals	mammal	NNS	O
,	,	,	O
there	there	EX	O
are	be	VBP	O
16	16	CD	O
isoforms	isoform	NNS	O
known	know	VBN	O
to	to	IN	O
date	date	NN	O
,	,	,	O
that	that	WDT	O
belong	belong	VBP	O
to	to	IN	O
the	the	DT	O
Î±-CA	Î±-CA	NNP	O
family	family	NN	O
and	and	CC	O
some	some	DT	O
of	of	IN	O
them	-PRON-	PRP	O
have	have	VBP	O
been	be	VBN	O
studied	study	VBN	O
as	as	IN	O
molecular	molecular	JJ	O
targets	target	NNS	O
to	to	TO	O
treat	treat	VB	O
human	human	JJ	O
diseases	disease	NNS	B
.	.	.	O

Traditionally	traditionally	RB	O
,	,	,	O
CA	CA	NNP	O
inhibitors	inhibitor	NNS	O
are	be	VBP	O
employed	employ	VBN	O
as	as	IN	O
diuretic	diuretic	JJ	O
and	and	CC	O
antiglaucoma	antiglaucoma	NN	O
drugs	drug	NNS	O
,	,	,	O
but	but	CC	O
other	other	JJ	O
clinical	clinical	JJ	O
applications	application	NNS	O
have	have	VBP	O
been	be	VBN	O
proposed	propose	VBN	O
,	,	,	O
including	include	VBG	O
the	the	DT	O
treatment	treatment	NN	O
of	of	IN	O
cancer	cancer	NN	O
,	,	,	O
obesity	obesity	NN	O
and	and	CC	O
epilepsy	epilepsy	NN	B
.	.	.	O

Regarding	regard	VBG	O
neglected	neglect	VBN	O
protozoan	protozoan	NN	O
diseases	disease	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
the	the	DT	O
American	american	JJ	O
trypanosomiasis	trypanosomiasis	NN	O
,	,	,	O
CA	CA	NNP	O
is	be	VBZ	O
emerging	emerge	VBG	O
as	as	IN	O
a	a	DT	O
new	new	JJ	O
therapeutic	therapeutic	JJ	O
target	target	NN	O
,	,	,	O
with	with	IN	O
its	-PRON-	PRP$	O
inhibitors	inhibitor	NNS	O
being	be	VBG	O
probably	probably	RB	O
able	able	JJ	O
to	to	TO	O
provide	provide	VB	O
an	an	DT	O
increased	increase	VBN	O
efficacy	efficacy	NN	O
and	and	CC	O
safety	safety	NN	O
in	in	IN	O
comparison	comparison	NN	O
with	with	IN	O
the	the	DT	O
current	current	JJ	O
treatments	treatment	NNS	B
.	.	.	O

American	american	JJ	O
trypanosomiasis	trypanosomiasis	NN	O
,	,	,	O
also	also	RB	O
known	know	VBN	O
as	as	IN	O
Chagas	Chagas	NNP	O
disease	disease	NN	O
,	,	,	O
is	be	VBZ	O
caused	cause	VBN	O
by	by	IN	O
the	the	DT	O
parasite	parasite	NN	O
Trypanosoma	Trypanosoma	NNP	O
cruzi	cruzi	NNS	B
.	.	.	O

It	-PRON-	PRP	O
was	be	VBD	O
first	first	RB	O
described	describe	VBN	O
by	by	IN	O
Carlos	Carlos	NNP	O
Chagas	Chagas	NNP	O
more	more	RBR	O
than	than	IN	O
a	a	DT	O
century	century	NN	O
ago	ago	RB	O
and	and	CC	O
it	-PRON-	PRP	O
affects	affect	VBZ	O
about	about	IN	O
8	8	CD	O
million	million	CD	O
people	people	NNS	O
worldwide	worldwide	RB	B
.	.	.	O

The	the	DT	O
disease	disease	NN	O
is	be	VBZ	O
characterised	characterise	VBN	O
by	by	IN	O
two	two	CD	O
phases	phase	NNS	O
:	:	:	O
an	an	DT	O
initial	initial	JJ	O
acute	acute	JJ	O
stage	stage	NN	O
which	which	WDT	O
usually	usually	RB	O
goes	go	VBZ	O
undetected	undetected	JJ	O
because	because	IN	O
it	-PRON-	PRP	O
lacks	lack	VBZ	O
specific	specific	JJ	O
symptoms	symptom	NNS	O
and	and	CC	O
;	;	:	O
a	a	DT	O
chronic	chronic	JJ	O
stage	stage	NN	O
that	that	WDT	O
may	may	MD	O
remain	remain	VB	O
asymptomatic	asymptomatic	JJ	O
but	but	CC	O
evolves	evolve	NNS	O
to	to	IN	O
clinical	clinical	JJ	O
manifestations	manifestation	NNS	O
in	in	IN	O
specific	specific	JJ	O
organs	organ	NNS	O
heart	heart	NN	O
,	,	,	O
digestive	digestive	JJ	O
system	system	NN	O
and/or	and/or	CC	O
nervous	nervous	JJ	O
system	system	NN	O
in	in	IN	O
about	about	RB	O
30	30	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
patients	patient	NNS	B
.	.	.	O

The	the	DT	O
therapeutic	therapeutic	JJ	O
arsenal	arsenal	NN	O
to	to	TO	O
treat	treat	VB	O
Chagas	Chagas	NNP	O
is	be	VBZ	O
composed	compose	VBN	O
of	of	IN	O
only	only	RB	O
two	two	CD	O
drugs	drug	NNS	O
,	,	,	O
benznidazole	benznidazole	NNP	O
and	and	CC	O
nifurtimox	nifurtimox	NNP	B
.	.	.	O

They	-PRON-	PRP	O
were	be	VBD	O
discovered	discover	VBN	O
more	more	JJR	O
than	than	IN	O
40âyears	40âyears	CD	O
ago	ago	RB	O
,	,	,	O
and	and	CC	O
they	-PRON-	PRP	O
are	be	VBP	O
mostly	mostly	RB	O
active	active	JJ	O
in	in	IN	O
the	the	DT	O
acute	acute	JJ	O
phase	phase	NN	O
of	of	IN	O
the	the	DT	O
disease	disease	NN	O
.	.	.	O

Their	-PRON-	PRP$	O
limited	limited	JJ	O
efficacy	efficacy	NN	O
in	in	IN	O
the	the	DT	O
chronic	chronic	JJ	O
phase	phase	NN	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
their	-PRON-	PRP$	O
considerable	considerable	JJ	O
toxicity	toxicity	NN	O
fostered	foster	VBD	O
the	the	DT	O
efforts	effort	NNS	O
to	to	TO	O
explore	explore	VB	O
the	the	DT	O
molecular	molecular	JJ	O
biology	biology	NN	O
of	of	IN	O
T.	T.	NNP	O
cruzi	cruzi	NNS	O
aiming	aim	VBG	O
to	to	TO	O
discover	discover	VB	O
new	new	JJ	O
therapeutic	therapeutic	JJ	O
targets	target	NNS	O
.	.	.	O

In	in	IN	O
this	this	DT	O
scenario	scenario	NN	O
,	,	,	O
the	the	DT	O
inhibition	inhibition	NN	O
of	of	IN	O
protozoan	protozoan	NN	O
CAs	ca	NNS	O
showed	show	VBD	O
up	up	RP	O
recently	recently	RB	O
as	as	IN	O
an	an	DT	O
interesting	interesting	JJ	O
option	option	NN	O
for	for	IN	O
the	the	DT	O
future	future	JJ	O
treatment	treatment	NN	O
of	of	IN	O
Chagas	Chagas	NNP	O
disease	disease	NN	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
other	other	JJ	O
neglected	neglect	VBN	O
pathologies	pathology	NNS	O
like	like	IN	O
Leishmaniasis	Leishmaniasis	NNP	B
.	.	.	O

At	at	IN	O
present	present	NN	O
,	,	,	O
only	only	RB	O
one	one	CD	O
T.	t.	NN	O
cruzi	cruzi	NNS	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
TcCA	tcca	NN	O
has	have	VBZ	O
been	be	VBN	O
described	describe	VBN	O
in	in	IN	O
the	the	DT	O
genome	genome	NN	O
of	of	IN	O
the	the	DT	O
parasite	parasite	NN	O
.	.	.	O

TcCA	TcCA	NNP	O
has	have	VBZ	O
recently	recently	RB	O
been	be	VBN	O
cloned	clone	VBN	O
and	and	CC	O
characterised	characterise	VBN	O
by	by	IN	O
Pan	Pan	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
It	-PRON-	PRP	O
belongs	belong	VBZ	O
to	to	IN	O
the	the	DT	O
Î±-CA	Î±-CA	NNP	O
family	family	NN	O
and	and	CC	O
shares	share	VBZ	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
topology	topology	NN	O
with	with	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
Î±-isoforms	î±-isoform	NNS	O
found	find	VBN	O
in	in	IN	O
mammals	mammal	NNS	O
:	:	:	O
the	the	DT	O
three	three	CD	O
His	-PRON-	PRP$	O
residues	residue	NNS	O
coordinating	coordinate	VBG	O
with	with	IN	O
one	one	CD	O
Zinc	Zinc	NNP	O
ion	ion	NN	O
,	,	,	O
and	and	CC	O
a	a	DT	O
fourth	fourth	JJ	O
coordination	coordination	NN	O
position	position	NN	O
occupied	occupy	VBN	O
by	by	IN	O
a	a	DT	O
water	water	NN	O
molecule	molecule	NN	O
at	at	IN	O
acidic	acidic	JJ	O
pH	pH	NNP	O
<	<	XX	O
7	7	LS	O
or	or	CC	O
by	by	IN	O
a	a	DT	O
hydroxide	hydroxide	NN	O
ion	ion	NN	O
at	at	IN	O
higher	high	JJR	O
pH	pH	NNP	O
values	value	NNS	B
,	,	,	B
.	.	.	O

The	the	DT	O
role	role	NN	O
of	of	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
in	in	IN	O
the	the	DT	O
pathogen	pathogen	NN	O
is	be	VBZ	O
still	still	RB	O
poorly	poorly	RB	O
understood	understand	VBN	O
,	,	,	O
but	but	CC	O
it	-PRON-	PRP	O
is	be	VBZ	O
known	know	VBN	O
that	that	IN	O
TcCA	tcca	NN	O
shows	show	VBZ	O
a	a	DT	O
very	very	RB	O
high	high	JJ	O
catalytic	catalytic	JJ	O
activity	activity	NN	B
,	,	,	B
.	.	.	O

It	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
hypothesised	hypothesise	VBN	O
that	that	IN	O
TcCA	tcca	NN	O
is	be	VBZ	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
proliferation	proliferation	NN	O
of	of	IN	O
the	the	DT	O
parasite	parasite	NN	O
when	when	WRB	O
it	-PRON-	PRP	O
is	be	VBZ	O
in	in	IN	O
the	the	DT	O
epimastigote	epimastigote	JJ	O
stage	stage	NN	B
.	.	.	O

This	this	DT	O
assumption	assumption	NN	O
was	be	VBD	O
supported	support	VBN	O
by	by	IN	O
some	some	DT	O
in	in	IN	O
vitro	vitro	FW	O
and	and	CC	O
ex	ex	NNP	O
vivo	vivo	NNP	O
studies	study	NNS	O
that	that	WDT	O
demonstrated	demonstrate	VBD	O
the	the	DT	O
ability	ability	NN	O
of	of	IN	O
TcCA	tcca	NN	O
inhibitors	inhibitor	NNS	O
to	to	TO	O
inhibit	inhibit	VB	O
epimastigote	epimastigote	JJ	O
proliferation	proliferation	NN	O
.	.	.	O

Regarding	regard	VBG	O
the	the	DT	O
chemical	chemical	NN	O
structure	structure	NN	O
of	of	IN	O
CA	CA	NNP	O
inhibitors	inhibitor	NNS	O
,	,	,	O
sulphonamides	sulphonamide	NNS	O
are	be	VBP	O
the	the	DT	O
main	main	JJ	O
class	class	NN	O
of	of	IN	O
compounds	compound	NNS	O
that	that	WDT	O
interacts	interact	VBZ	O
with	with	IN	O
CAs	CAs	NNP	O
in	in	IN	O
mammals	mammal	NNS	O
,	,	,	O
especially	especially	RB	O
with	with	IN	O
CA	CA	NNP	O
II	II	NNP	O
which	which	WDT	O
is	be	VBZ	O
,	,	,	O
by	by	IN	O
far	far	RB	O
,	,	,	O
the	the	DT	O
most	most	RBS	O
studied	studied	JJ	O
isoform	isoform	NN	O
)	)	-RRB-	B
.	.	.	O

The	the	DT	O
classical	classical	JJ	O
mechanism	mechanism	NN	O
of	of	IN	O
inhibition	inhibition	NN	O
involves	involve	VBZ	O
the	the	DT	O
interaction	interaction	NN	O
of	of	IN	O
the	the	DT	O
sulphonamide	sulphonamide	JJ	O
nitrogen	nitrogen	NN	O
atom	atom	NN	O
with	with	IN	O
the	the	DT	O
Zinc	Zinc	NNP	O
ion	ion	NN	O
,	,	,	O
which	which	WDT	O
places	place	VBZ	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
in	in	IN	O
the	the	DT	O
position	position	NN	O
originally	originally	RB	O
occupied	occupy	VBN	O
by	by	IN	O
water	water	NN	O
or	or	CC	O
the	the	DT	O
hydroxide	hydroxide	NN	O
ion	ion	NN	O
)	)	-RRB-	B
,	,	,	B
.	.	.	O

TcCA	tcca	NN	O
is	be	VBZ	O
also	also	RB	O
inhibited	inhibit	VBN	O
by	by	IN	O
other	other	JJ	O
compound	compound	NN	O
families	family	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
thiols	thiol	NNS	O
and	and	CC	O
hydroxamates	hydroxamate	VBZ	B
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
molecules	molecule	NNS	O
from	from	IN	O
these	these	DT	O
two	two	CD	O
classes	class	NNS	O
showed	show	VBD	O
better	well	JJR	O
potency	potency	NN	O
and	and	CC	O
selectivity	selectivity	NN	O
in	in	IN	O
vitro	vitro	FW	O
compared	compare	VBN	O
to	to	IN	O
sulphonamides	sulphonamide	NNS	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
promising	promise	VBG	O
in	in	IN	O
vivo	vivo	NNP	O
profiles	profile	NNS	O
,	,	,	O
by	by	IN	O
inhibiting	inhibit	VBG	O
the	the	DT	O
three	three	CD	O
phases	phase	NNS	O
of	of	IN	O
the	the	DT	O
pathogenâs	pathogenâs	NNP	O
life	life	NN	O
cycle	cycle	NN	O
trypomastigote	trypomastigote	NNP	O
,	,	,	O
amastigote	amastigote	VB	O
and	and	CC	O
epimastigote	epimastigote	VB	O
)	)	-RRB-	B
.	.	.	O

Following	follow	VBG	O
these	these	DT	O
previous	previous	JJ	O
investigations	investigation	NNS	O
,	,	,	O
we	-PRON-	PRP	O
investigate	investigate	VBP	O
here	here	RB	O
the	the	DT	O
capacity	capacity	NN	O
of	of	IN	O
a	a	DT	O
new	new	JJ	O
set	set	NN	O
of	of	IN	O
compounds	compound	NNS	O
to	to	TO	O
inhibit	inhibit	VB	O
TcCA	tcca	NN	O
.	.	.	O

One	one	CD	O
of	of	IN	O
the	the	DT	O
main	main	JJ	O
challenges	challenge	NNS	O
in	in	IN	O
the	the	DT	O
development	development	NN	O
of	of	IN	O
new	new	JJ	O
CA	CA	NNP	O
inhibitors	inhibitor	NNS	O
is	be	VBZ	O
to	to	TO	O
find	find	VB	O
selectivity	selectivity	NN	O
against	against	IN	O
the	the	DT	O
specific	specific	JJ	O
isoforms	isoform	NNS	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
disease	disease	NN	O
,	,	,	O
to	to	TO	O
avoid	avoid	VB	O
tolerance	tolerance	NN	O
problems	problem	NNS	O
and	and	CC	O
to	to	TO	O
improve	improve	VB	O
the	the	DT	O
therapeutic	therapeutic	JJ	O
safety	safety	NN	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
the	the	DT	O
selection	selection	NN	O
of	of	IN	O
the	the	DT	O
candidates	candidate	NNS	O
for	for	IN	O
biological	biological	JJ	O
assays	assay	NNS	O
was	be	VBD	O
guided	guide	VBN	O
by	by	IN	O
the	the	DT	O
results	result	NNS	O
of	of	IN	O
a	a	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
protocol	protocol	NN	O
applied	apply	VBD	O
to	to	IN	O
a	a	DT	O
set	set	NN	O
of	of	IN	O
compounds	compound	NNS	O
that	that	WDT	O
share	share	VBP	O
a	a	DT	O
zinc	zinc	NN	O
binding	bind	VBG	O
function	function	NN	O
sulphamides	sulphamide	NNS	O
,	,	,	O
and	and	CC	O
their	-PRON-	PRP$	O
bioisosters	bioisoster	NNS	O
sulphamates	sulphamate	NNS	O
and	and	CC	O
sulphonamides	sulphonamide	NNS	O
and	and	CC	O
have	have	VB	O
low	low	JJ	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
against	against	IN	O
the	the	DT	O
ubiquitous	ubiquitous	JJ	O
human	human	JJ	O
isoform	isoform	NN	O
CA	CA	NNP	O
II	II	NNP	O
,	,	,	O
which	which	WDT	O
could	could	MD	O
be	be	VB	O
considered	consider	VBN	O
as	as	IN	O
an	an	DT	O
anti	anti	NN	O
-	-	NN	O
target	target	NN	O
.	.	.	O

Our	-PRON-	PRP$	O
investigation	investigation	NN	O
initiated	initiate	VBD	O
with	with	IN	O
the	the	DT	O
construction	construction	NN	O
of	of	IN	O
three	three	CD	O
-	-	HYPH	O
dimensional	dimensional	JJ	O
models	model	NNS	O
of	of	IN	O
TcCA	tcca	NN	O
,	,	,	O
since	since	IN	O
the	the	DT	O
experimental	experimental	JJ	O
structure	structure	NN	O
of	of	IN	O
the	the	DT	O
target	target	NN	O
is	be	VBZ	O
not	not	RB	O
yet	yet	RB	O
available	available	JJ	O
.	.	.	O

A	a	DT	O
test	test	NN	O
set	set	NN	O
of	of	IN	O
87	87	CD	O
known	know	VBN	O
TcCA	tcca	NN	O
inhibitors	inhibitor	NNS	O
was	be	VBD	O
then	then	RB	O
compiled	compile	VBN	O
from	from	IN	O
literature	literature	NN	O
and	and	CC	O
used	use	VBD	O
to	to	TO	O
select	select	VB	O
the	the	DT	O
best	good	JJS	O
docking	docking	NN	O
model	model	NN	O
for	for	IN	O
the	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
,	,	,	O
based	base	VBN	O
on	on	IN	O
the	the	DT	O
correlation	correlation	NN	O
between	between	IN	O
the	the	DT	O
docking	docking	NN	O
score	score	NN	O
and	and	CC	O
the	the	DT	O
experimentally	experimentally	RB	O
determined	determine	VBN	O
pKI	pKI	NNP	O
.	.	.	O

Finally	finally	RB	O
,	,	,	O
an	an	DT	O
in	in	IN	O
-	-	HYPH	O
house	house	NN	O
dataset	dataset	NN	O
of	of	IN	O
255	255	CD	O
compounds	compound	NNS	O
was	be	VBD	O
screened	screen	VBN	O
and	and	CC	O
10	10	CD	O
compounds	compound	NNS	O
were	be	VBD	O
tested	test	VBN	O
against	against	IN	O
TcCA	tcca	NN	O
.	.	.	O

Anti	anti	JJ	O
-	-	JJ	O
trypanosomal	trypanosomal	JJ	O
effects	effect	NNS	O
were	be	VBD	O
also	also	RB	O
investigated	investigate	VBN	O
for	for	IN	O
the	the	DT	O
selected	select	VBN	O
candidates	candidate	NNS	O
.	.	.	O

Information	information	NN	O
about	about	IN	O
the	the	DT	O
identity	identity	NN	O
of	of	IN	O
the	the	DT	O
structures	structure	NNS	O
of	of	IN	O
the	the	DT	O
test	test	NN	O
set	set	NN	O
Table	table	NN	O
S1	S1	NNS	O
and	and	CC	O
the	the	DT	O
dataset	dataset	NN	O
for	for	IN	O
screening	screening	NN	O
is	be	VBZ	O
given	give	VBN	O
as	as	IN	O
supporting	support	VBG	O
information	information	NN	O
Table	table	NN	O
S2	S2	NNP	O
see	see	VB	O
Supplementary	supplementary	JJ	O
information	information	NN	O
for	for	IN	O
details)We	details)We	NNP	O
applied	apply	VBD	O
the	the	DT	O
Meier	Meier	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
algorithm	algorithm	VBP	O
as	as	IN	O
implemented	implement	VBN	O
in	in	IN	O
the	the	DT	O
HHPred	HHPred	NNP	O
Server	Server	NNP	B
to	to	TO	O
construct	construct	VB	O
our	-PRON-	PRP$	O
initial	initial	JJ	O
model	model	NN	O
of	of	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
.	.	.	O

The	the	DT	O
sequence	sequence	NN	O
of	of	IN	O
TcCA	tcca	NN	O
was	be	VBD	O
retrieved	retrieve	VBN	O
from	from	IN	O
Uniprot	Uniprot	NNP	O
Q4CVY4	Q4CVY4	NNP	O
)	)	-RRB-	B
.	.	.	O

A	a	DT	O
multi	multi	JJ	O
-	-	JJ	O
template	template	JJ	O
model	model	NN	O
was	be	VBD	O
generated	generate	VBN	O
combining	combine	VBG	O
the	the	DT	O
top	top	JJ	O
10	10	CD	O
templates	template	NNS	O
ranked	rank	VBN	O
by	by	IN	O
its	-PRON-	PRP$	O
alignment	alignment	NN	O
score	score	NN	O
.	.	.	O

The	the	DT	O
quality	quality	NN	O
of	of	IN	O
the	the	DT	O
model	model	NN	O
was	be	VBD	O
evaluated	evaluate	VBN	O
with	with	IN	O
the	the	DT	O
metrics	metric	NNS	O
provided	provide	VBN	O
by	by	IN	O
the	the	DT	O
server	server	NN	O
,	,	,	O
Molprobity	Molprobity	NNP	O
and	and	CC	O
the	the	DT	O
QMEAN	QMEAN	NNP	O
scoring	score	VBG	O
functions	function	NNS	B
.	.	.	O

Then	then	RB	O
,	,	,	O
the	the	DT	O
macrostructure	macrostructure	NN	O
was	be	VBD	O
submitted	submit	VBN	O
to	to	IN	O
an	an	DT	O
iterative	iterative	JJ	O
refinement	refinement	NN	O
process	process	NN	O
,	,	,	O
combining	combine	VBG	O
Rosetta	Rosetta	NNP	O
and	and	CC	O
Molecular	Molecular	NNP	O
Dynamics	Dynamics	NNPS	O
MD	MD	NNP	O
simulations	simulation	NNS	O
.	.	.	O

For	for	IN	O
that	that	DT	O
purpose	purpose	NN	O
,	,	,	O
we	-PRON-	PRP	O
used	use	VBD	O
Rosettaâs	rosettaâs	CD	O
Fast	Fast	NNP	O
Relax	Relax	NNP	O
algorithm	algorithm	NN	O
with	with	IN	O
the	the	DT	O
metalloproteins	metalloprotein	NNS	O
modification	modification	NN	O
,	,	,	O
which	which	WDT	O
imposes	impose	VBZ	O
constraints	constraint	NNS	O
on	on	IN	O
the	the	DT	O
Zinc	Zinc	NNP	O
ion	ion	NN	O
and	and	CC	O
its	-PRON-	PRP$	O
coordinating	coordinate	VBG	O
residues	residue	NNS	O
to	to	TO	O
preserve	preserve	VB	O
the	the	DT	O
coordination	coordination	NN	O
geometry	geometry	NN	O
during	during	IN	O
the	the	DT	O
simulation	simulation	NN	B
.	.	.	O

Briefly	briefly	RB	O
,	,	,	O
the	the	DT	O
protocol	protocol	NN	O
consists	consist	VBZ	O
of	of	IN	O
alternating	alternate	VBG	O
cycles	cycle	NNS	O
of	of	IN	O
rotamer	rotamer	NN	O
repacking	repacking	JJ	O
and	and	CC	O
gradient	gradient	NN	O
-	-	HYPH	O
based	base	VBN	O
energy	energy	NN	O
minimisation	minimisation	NN	O
,	,	,	O
increasing	increase	VBG	O
the	the	DT	O
repulsive	repulsive	JJ	O
contributions	contribution	NNS	O
within	within	IN	O
each	each	DT	O
cycle	cycle	NN	O
.	.	.	O

After	after	IN	O
generating	generate	VBG	O
100	100	CD	O
new	new	JJ	O
refined	refined	JJ	O
models	model	NNS	O
,	,	,	O
the	the	DT	O
top	top	JJ	O
scoring	score	VBG	O
decoy	decoy	NN	O
was	be	VBD	O
selected	select	VBN	O
as	as	IN	O
the	the	DT	O
starting	starting	NN	O
point	point	NN	O
for	for	IN	O
MD	MD	NNP	O
simulations	simulation	NNS	O
.	.	.	O

MD	MD	NNP	O
simulations	simulation	NNS	O
were	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
with	with	IN	O
the	the	DT	O
Amber16	Amber16	NNP	O
package	package	NN	B
,	,	,	O
using	use	VBG	O
the	the	DT	O
FF14SB	FF14SB	NNP	O
force	force	NNP	O
field	field	NN	O
and	and	CC	O
the	the	DT	O
Zinc	Zinc	NNP	O
AMBER	AMBER	NNP	O
force	force	NN	O
field	field	NN	O
ZAFF	ZAFF	NNP	O
modification	modification	NN	O
designed	design	VBN	O
for	for	IN	O
4-coordinated	4-coordinated	CD	O
Zinc	Zinc	NNP	O
metal	metal	NN	O
centres	centre	VBZ	B
.	.	.	O

Because	because	IN	O
the	the	DT	O
three	three	CD	O
His	-PRON-	PRP$	O
residues	residue	NNS	O
that	that	WDT	O
coordinate	coordinate	VBP	O
with	with	IN	O
the	the	DT	O
zinc	zinc	NN	O
ion	ion	NN	O
in	in	IN	O
human	human	JJ	O
CA	CA	NNP	O
are	be	VBP	O
also	also	RB	O
conserved	conserve	VBN	O
in	in	IN	O
TcCA	tcca	NN	O
,	,	,	O
we	-PRON-	PRP	O
assumed	assume	VBD	O
a	a	DT	O
tetrahedral	tetrahedral	JJ	O
coordination	coordination	NN	O
for	for	IN	O
the	the	DT	O
Zinc	Zinc	NNP	O
atom	atom	NN	O
and	and	CC	O
a	a	DT	O
water	water	NN	O
molecule	molecule	NN	O
was	be	VBD	O
manually	manually	RB	O
placed	place	VBN	O
in	in	IN	O
the	the	DT	O
fourth	fourth	JJ	O
vertex	vertex	NNP	O
to	to	TO	O
fulfil	fulfil	VB	O
the	the	DT	O
coordination	coordination	NN	O
geometry	geometry	NN	O
.	.	.	O

Thus	thus	RB	O
,	,	,	O
the	the	DT	O
centre	centre	NN	O
ID	ID	NNP	O
No	No	NNP	O
.	.	NN	O

6	6	CD	O
in	in	IN	O
the	the	DT	O
ZAFF	ZAFF	NNP	O
force	force	NN	O
field	field	NN	O
was	be	VBD	O
selected	select	VBN	O
to	to	TO	O
set	set	VB	O
the	the	DT	O
parameters	parameter	NNS	O
,	,	,	O
which	which	WDT	O
were	be	VBD	O
derived	derive	VBN	O
by	by	IN	O
Mertz	Mertz	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	O

from	from	IN	O
human	human	JJ	O
CA	CA	NNP	O
-	-	HYPH	O
II	II	NNP	O
crystal	crystal	NN	O
structure	structure	NN	O
1CA2	1ca2	CD	O
using	use	VBG	O
the	the	DT	O
MCPB	MCPB	NNP	O
program	program	NN	B
.	.	.	O

The	the	DT	O
structure	structure	NN	O
was	be	VBD	O
solvated	solvate	VBN	O
in	in	IN	O
an	an	DT	O
octahedral	octahedral	JJ	O
box	box	NN	O
of	of	IN	O
TIP3P	tip3p	CD	O
water	water	NN	O
molecules	molecule	NNS	O
,	,	,	O
and	and	CC	O
Clâ	clâ	NN	O
ions	ion	NNS	O
were	be	VBD	O
added	add	VBN	O
to	to	TO	O
neutralise	neutralise	VB	O
the	the	DT	O
system	system	NN	O
.	.	.	O

Minimisation	Minimisation	NNP	O
of	of	IN	O
the	the	DT	O
system	system	NN	O
was	be	VBD	O
performed	perform	VBN	O
in	in	IN	O
four	four	CD	O
sequential	sequential	JJ	O
steps	step	NNS	O
.	.	.	O

First	first	RB	O
,	,	,	O
only	only	RB	O
hydrogen	hydrogen	NN	O
atoms	atom	NNS	O
were	be	VBD	O
minimised	minimise	VBN	O
.	.	.	O

Second	second	RB	O
,	,	,	O
only	only	RB	O
the	the	DT	O
solvent	solvent	NN	O
around	around	IN	O
the	the	DT	O
protein	protein	NN	O
was	be	VBD	O
allowed	allow	VBN	O
to	to	TO	O
move	move	VB	O
.	.	.	O

Third	third	RB	O
,	,	,	O
only	only	RB	O
protein	protein	NN	O
side	side	NN	O
chains	chain	NNS	O
and	and	CC	O
solvent	solvent	NN	O
were	be	VBD	O
minimised	minimise	VBN	O
,	,	,	O
fixing	fix	VBG	O
the	the	DT	O
position	position	NN	O
of	of	IN	O
the	the	DT	O
protein	protein	NN	O
backbone	backbone	NN	O
atoms	atom	NNS	O
.	.	.	O

Finally	finally	RB	O
,	,	,	O
the	the	DT	O
whole	whole	JJ	O
system	system	NN	O
was	be	VBD	O
minimised	minimise	VBN	O
with	with	IN	O
no	no	DT	O
constraints	constraint	NNS	O
.	.	.	O

Every	every	DT	O
minimisation	minimisation	NN	O
stage	stage	NN	O
involved	involve	VBD	O
2500	2500	CD	O
steepest	steep	JJS	O
descent	descent	NN	O
steps	step	NNS	O
,	,	,	O
followed	follow	VBN	O
by	by	IN	O
7500	7500	CD	O
steps	step	NNS	O
of	of	IN	O
conjugate	conjugate	NN	O
gradient	gradient	NN	O
.	.	.	O

Then	then	RB	O
,	,	,	O
the	the	DT	O
system	system	NN	O
was	be	VBD	O
carefully	carefully	RB	O
heated	heat	VBN	O
to	to	IN	O
298.15âK	298.15âk	CD	O
and	and	CC	O
equilibrated	equilibrate	VBN	O
in	in	IN	O
six	six	CD	O
consecutive	consecutive	JJ	O
steps	step	NNS	O
,	,	,	O
starting	start	VBG	O
in	in	IN	O
NVT	NVT	NNP	O
conditions	condition	NNS	O
and	and	CC	O
then	then	RB	O
switching	switch	VBG	O
to	to	IN	O
an	an	DT	O
NPT	NPT	NNP	O
ensemble	ensemble	JJ	O
to	to	TO	O
equilibrate	equilibrate	VB	O
the	the	DT	O
system	system	NN	O
density	density	NN	O
,	,	,	O
progressively	progressively	RB	O
relieving	relieve	VBG	O
constraints	constraint	NNS	O
to	to	TO	O
achieve	achieve	VB	O
a	a	DT	O
proper	proper	JJ	O
equilibration	equilibration	NN	O
.	.	.	O

A	a	DT	O
total	total	NN	O
of	of	IN	O
50âns	50âns	CD	O
was	be	VBD	O
simulated	simulate	VBN	O
,	,	,	O
monitoring	monitor	VBG	O
the	the	DT	O
protein	protein	NN	O
backbone	backbone	NN	O
RMSD	RMSD	NNP	O
as	as	IN	O
a	a	DT	O
simulation	simulation	NN	O
convergence	convergence	NN	O
criterion	criterion	NN	O
,	,	,	O
and	and	CC	O
10	10	CD	O
representative	representative	JJ	O
snapshots	snapshot	NNS	O
were	be	VBD	O
extracted	extract	VBN	O
by	by	IN	O
clustering	cluster	VBG	O
analysis	analysis	NN	O
.	.	.	O

For	for	IN	O
that	that	DT	O
purpose	purpose	NN	O
,	,	,	O
the	the	DT	O
whole	whole	JJ	O
trajectory	trajectory	NN	O
was	be	VBD	O
clustered	cluster	VBN	O
using	use	VBG	O
the	the	DT	O
K	K	NNP	O
-	-	HYPH	O
means	means	NNP	O
algorithm	algorithm	NNP	O
implemented	implement	VBN	O
in	in	IN	O
cpptraj	cpptraj	NNS	O
,	,	,	O
fixing	fix	VBG	O
the	the	DT	O
number	number	NN	O
of	of	IN	O
clusters	cluster	NNS	O
Kâ=â10	Kâ=â10	NNP	O
and	and	CC	O
choosing	choose	VBG	O
the	the	DT	O
cluster	cluster	NN	O
centroid	centroid	NNP	O
as	as	IN	O
the	the	DT	O
representative	representative	JJ	O
structure	structure	NN	O
in	in	IN	O
each	each	DT	O
case	case	NN	O
.	.	.	O

Finally	finally	RB	O
,	,	,	O
all	all	PDT	O
the	the	DT	O
selected	select	VBN	O
snapshots	snapshot	NNS	O
were	be	VBD	O
subjected	subject	VBN	O
to	to	IN	O
a	a	DT	O
later	later	JJ	O
refinement	refinement	JJ	O
step	step	NN	O
using	use	VBG	O
Rosettaâs	Rosettaâs	NNP	O
Fast	Fast	NNP	O
Relax	Relax	NNP	O
protocol	protocol	NN	O
described	describe	VBN	O
before	before	IN	B
,	,	,	O
to	to	TO	O
sample	sample	VB	O
high	high	JJ	O
-	-	HYPH	O
quality	quality	NN	O
decoys	decoy	NNS	O
around	around	IN	O
the	the	DT	O
starting	starting	NN	O
conformation	conformation	NN	O
.	.	.	O

These	these	DT	O
10	10	CD	O
final	final	JJ	O
TcCA	tcca	NN	O
structural	structural	JJ	O
models	model	NNS	O
were	be	VBD	O
used	use	VBN	O
for	for	IN	O
docking	docking	NN	O
simulation	simulation	NN	O
.	.	.	O

A	a	DT	O
validation	validation	NN	O
set	set	NN	O
of	of	IN	O
87	87	CD	O
molecules	molecule	NNS	O
tested	test	VBN	O
against	against	IN	O
the	the	DT	O
TcCA	tcca	NN	O
was	be	VBD	O
compiled	compile	VBN	O
from	from	IN	O
literature	literature	NN	B
.	.	.	O

It	-PRON-	PRP	O
includes	include	VBZ	O
compounds	compound	NNS	O
with	with	IN	O
different	different	JJ	O
chemical	chemical	NN	O
structures	structure	NNS	O
but	but	CC	O
mostly	mostly	RB	O
presenting	present	VBG	O
sulphonamides	sulphonamide	NNS	O
,	,	,	O
thiols	thiol	NNS	O
and	and	CC	O
hydroxamates	hydroxamate	NNS	O
as	as	IN	O
Zinc	Zinc	NNP	O
binding	binding	NN	O
functions	function	NNS	O
.	.	.	O

The	the	DT	O
activity	activity	NN	O
values	value	NNS	O
KI	KI	NNP	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
range	range	VBP	O
between	between	IN	O
0.51	0.51	CD	O
and	and	CC	O
84,000ânM.	84,000ânm.	CD	O
These	these	DT	O
reported	report	VBN	O
activities	activity	NNS	O
were	be	VBD	O
transformed	transform	VBN	O
to	to	IN	O
pKI	pki	JJ	O
values	value	NNS	O
Table	table	NN	O
S1	s1	NN	O
.	.	.	O

Benzoxaboroles	benzoxaborole	NNS	O
described	describe	VBN	O
by	by	IN	O
Nocentini	Nocentini	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
were	be	VBD	O
excluded	exclude	VBN	O
from	from	IN	O
the	the	DT	O
dataset	dataset	NN	O
because	because	IN	O
the	the	DT	O
docking	docking	NN	O
forcefield	forcefield	NN	O
does	do	VBZ	O
not	not	RB	O
include	include	VB	O
parameters	parameter	NNS	O
for	for	IN	O
boron	boron	NN	O
atoms	atom	NNS	O
.	.	.	O

For	for	IN	O
each	each	DT	O
molecule	molecule	NN	O
,	,	,	O
the	the	DT	O
most	most	RBS	O
abundant	abundant	JJ	O
species	specie	NNS	O
at	at	IN	O
pH	pH	NNP	O
7.4	7.4	CD	O
was	be	VBD	O
calculated	calculate	VBN	O
with	with	IN	O
ChemAxon	ChemAxon	NNP	B
,	,	,	O
considering	consider	VBG	O
tautomerization	tautomerization	NN	O
and	and	CC	O
resonance	resonance	NN	O
effects	effect	NNS	O
.	.	.	O

Finally	finally	RB	O
,	,	,	O
5000	5000	CD	O
steps	step	NNS	O
of	of	IN	O
geometry	geometry	NN	O
optimisation	optimisation	NN	O
were	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
with	with	IN	O
the	the	DT	O
MMFF94S	MMFF94S	NNP	O
force	force	NN	O
field	field	NN	O
,	,	,	O
to	to	TO	O
get	get	VB	O
reasonable	reasonable	JJ	O
starting	start	VBG	O
geometries	geometry	NNS	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
worth	worth	JJ	O
noticing	notice	VBG	O
that	that	IN	O
thiol	thiol	NN	O
compounds	compound	NNS	O
were	be	VBD	O
predicted	predict	VBN	O
to	to	TO	O
be	be	VB	O
deprotonated	deprotonate	VBN	O
at	at	IN	O
the	the	DT	O
given	give	VBN	O
pH	pH	NNP	O
,	,	,	O
with	with	IN	O
the	the	DT	O
negative	negative	JJ	O
charge	charge	NN	O
stabilised	stabilise	VBN	O
by	by	IN	O
a	a	DT	O
nitrogen	nitrogen	NN	O
atom	atom	NN	O
from	from	IN	O
an	an	DT	O
adjacent	adjacent	JJ	O
heteroaromatic	heteroaromatic	JJ	O
ring	ring	NN	O
that	that	WDT	O
is	be	VBZ	O
present	present	JJ	O
in	in	IN	O
these	these	DT	O
molecules	molecule	NNS	O
.	.	.	O

The	the	DT	O
docking	docking	NN	O
calculations	calculation	NNS	O
were	be	VBD	O
run	run	VBN	O
with	with	IN	O
AutoDockZN	AutoDockZN	NNP	B
,	,	,	O
a	a	DT	O
software	software	NN	O
that	that	WDT	O
includes	include	VBZ	O
modifications	modification	NNS	O
of	of	IN	O
the	the	DT	O
classic	classic	JJ	O
AutoDock4	AutoDock4	NNP	O
force	force	NN	O
field	field	NN	O
with	with	IN	O
specific	specific	JJ	O
parameters	parameter	NNS	O
for	for	IN	O
the	the	DT	O
zinc	zinc	NN	O
ion	ion	NN	O
.	.	.	O

This	this	DT	O
forcefield	forcefield	NN	O
has	have	VBZ	O
proven	prove	VBN	O
to	to	TO	O
overcome	overcome	VB	O
the	the	DT	O
performance	performance	NN	O
of	of	IN	O
the	the	DT	O
original	original	JJ	O
AutoDock4	AutoDock4	NNP	B
for	for	IN	O
docking	dock	VBG	O
small	small	JJ	O
molecules	molecule	NNS	O
into	into	IN	O
Zinc	Zinc	NNP	O
metalloproteins	metalloprotein	NNS	O
,	,	,	O
in	in	IN	O
both	both	DT	O
binding	bind	VBG	O
energy	energy	NN	O
estimation	estimation	NN	O
and	and	CC	O
pose	pose	VB	O
prediction	prediction	NN	O
.	.	.	O

The	the	DT	O
grid	grid	NN	O
maps	map	NNS	O
were	be	VBD	O
constructed	construct	VBN	O
centred	centre	VBN	O
on	on	IN	O
the	the	DT	O
Zinc	Zinc	NNP	O
atom	atom	NN	O
for	for	IN	O
every	every	DT	O
TcCA	tcca	NN	O
model	model	NN	O
with	with	IN	O
Autogrid	autogrid	JJ	O
4.2.6	4.2.6	NNP	B
.	.	.	O

They	-PRON-	PRP	O
covered	cover	VBD	O
60	60	CD	O
points	point	NNS	O
in	in	IN	O
each	each	DT	O
dimension	dimension	NN	O
from	from	IN	O
the	the	DT	O
Zinc	Zinc	NNP	O
centre	centre	NN	O
,	,	,	O
with	with	IN	O
a	a	DT	O
spacing	spacing	NN	O
of	of	IN	O
0.375âÃ	0.375âã	ADD	O
		_SP	O
.	.	.	O

The	the	DT	O
docking	docking	NN	O
simulations	simulation	NNS	O
were	be	VBD	O
run	run	VBN	O
by	by	IN	O
considering	consider	VBG	O
a	a	DT	O
population	population	NN	O
size	size	NN	O
of	of	IN	O
300	300	CD	O
and	and	CC	O
an	an	DT	O
elitism	elitism	NN	O
of	of	IN	O
1	1	CD	O
.	.	.	O

We	-PRON-	PRP	O
performed	perform	VBD	O
100	100	CD	O
runs	run	NNS	O
of	of	IN	O
the	the	DT	O
Lamarckian	Lamarckian	NNP	O
Genetic	Genetic	NNP	O
Algorithm	Algorithm	NNP	O
with	with	IN	O
AutoDock4.2	autodock4.2	JJ	B
.	.	.	O

The	the	DT	O
scoring	score	VBG	O
power	power	NN	O
of	of	IN	O
every	every	DT	O
docking	docking	NN	O
model	model	NN	O
combination	combination	NN	O
of	of	IN	O
docking	docking	NN	O
programme	programme	NN	O
and	and	CC	O
TcCA	TcCA	NNP	O
structural	structural	JJ	O
model	model	NN	O
was	be	VBD	O
evaluated	evaluate	VBN	O
by	by	IN	O
calculating	calculate	VBG	O
the	the	DT	O
Pearson	Pearson	NNP	O
correlation	correlation	NN	O
coefficient	coefficient	NN	O
Pearsonâs	Pearsonâs	NNP	O
r	r	NN	O
between	between	IN	O
the	the	DT	O
docking	docking	NN	O
scores	score	NNS	O
and	and	CC	O
the	the	DT	O
pKI	pki	JJ	O
values	value	NNS	O
for	for	IN	O
all	all	PDT	O
the	the	DT	O
compounds	compound	NNS	O
in	in	IN	O
the	the	DT	O
validation	validation	NN	O
set	set	VBN	O
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
we	-PRON-	PRP	O
evaluated	evaluate	VBD	O
the	the	DT	O
ranking	ranking	JJ	O
power	power	NN	O
of	of	IN	O
the	the	DT	O
models	model	NNS	O
by	by	IN	O
calculating	calculate	VBG	O
Kendallâs	kendallâs	CD	O
rank	rank	NN	O
correlation	correlation	NN	O
coefficient	coefficient	NN	O
Tau	Tau	NNP	O
B	B	NNP	O
and	and	CC	O
Spearmanâs	spearmanâs	CD	O
rank	rank	NN	O
correlation	correlation	NN	O
coefficient	coefficient	NN	O
Rho	Rho	NNP	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
evaluate	evaluate	VB	O
the	the	DT	O
modelâs	modelâs	CD	O
performance	performance	NN	O
as	as	IN	O
a	a	DT	O
classifier	classifier	NN	O
,	,	,	O
compounds	compound	NNS	O
were	be	VBD	O
defined	define	VBN	O
either	either	CC	O
as	as	IN	O
active	active	JJ	O
or	or	CC	O
inactive	inactive	JJ	O
based	base	VBN	O
on	on	IN	O
the	the	DT	O
reported	report	VBN	O
KI	KI	NNP	O
value	value	NN	O
.	.	.	O

To	to	IN	O
this	this	DT	O
end	end	NN	O
,	,	,	O
compounds	compound	VBZ	O
with	with	IN	O
a	a	DT	O
KI	KI	NNP	O
value	value	NN	O
lower	low	JJR	O
than	than	IN	O
1âÎ¼M	1âî¼m	CD	O
were	be	VBD	O
considered	consider	VBN	O
as	as	IN	O
actives	active	NNS	O
.	.	.	O

Then	then	RB	O
,	,	,	O
the	the	DT	O
Area	Area	NNP	O
Under	under	IN	O
the	the	DT	O
Receiver	Receiver	NNP	O
Operating	operate	VBG	O
Characteristic	Characteristic	NNP	O
Curve	curve	NN	O
ROC	ROC	NNP	O
-	-	HYPH	O
AUC	AUC	NNP	O
was	be	VBD	O
calculated	calculate	VBN	O
as	as	IN	O
a	a	DT	O
metric	metric	NN	O
to	to	TO	O
evaluate	evaluate	VB	O
the	the	DT	O
discriminating	discriminate	VBG	O
power	power	NN	O
of	of	IN	O
the	the	DT	O
model	model	NN	O
.	.	.	O

Figure	figure	NN	O
1	1	CD	O
shows	show	VBZ	O
a	a	DT	O
schematic	schematic	JJ	O
representation	representation	NN	O
of	of	IN	O
the	the	DT	O
methods	method	NNS	O
used	use	VBN	O
in	in	IN	O
this	this	DT	O
investigation	investigation	NN	O
to	to	TO	O
create	create	VB	O
and	and	CC	O
validate	validate	VB	O
the	the	DT	O
structure	structure	NN	O
-	-	HYPH	O
based	base	VBN	O
predictive	predictive	JJ	O
model	model	NN	O
of	of	IN	O
TcCA	tcca	NN	O
for	for	IN	O
the	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
campaign	campaign	NN	O
.	.	.	O

Schematic	schematic	JJ	O
illustration	illustration	NN	O
of	of	IN	O
the	the	DT	O
methods	method	NNS	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
construction	construction	NN	O
of	of	IN	O
the	the	DT	O
model	model	NN	O
for	for	IN	O
the	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
.	.	.	O

The	the	DT	O
progress	progress	NN	O
of	of	IN	O
the	the	DT	O
investigation	investigation	NN	O
is	be	VBZ	O
described	describe	VBN	O
as	as	IN	O
a	a	DT	O
cyan	cyan	NN	O
circle	circle	NN	O
in	in	IN	O
each	each	DT	O
step	step	NN	O
of	of	IN	O
the	the	DT	O
molecular	molecular	JJ	O
modelling	modelling	NN	O
.	.	.	O

The	the	DT	O
previously	previously	RB	O
described	describe	VBN	O
docking	docking	NNP	O
protocol	protocol	NNP	O
was	be	VBD	O
selected	select	VBN	O
to	to	TO	O
screen	screen	VB	O
an	an	DT	O
inhouse	inhouse	NN	O
library	library	NN	O
of	of	IN	O
255	255	CD	O
compounds	compound	NNS	O
Table	table	NN	O
S2	s2	NN	O
.	.	.	O

Some	some	DT	O
of	of	IN	O
these	these	DT	O
compounds	compound	NNS	O
were	be	VBD	O
synthesised	synthesise	VBN	O
in	in	IN	O
our	-PRON-	PRP$	O
lab	lab	NN	B
,	,	,	O
whilst	whilst	IN	O
others	other	NNS	O
were	be	VBD	O
commercial	commercial	JJ	O
compounds	compound	NNS	O
like	like	IN	O
the	the	DT	O
artificial	artificial	JJ	O
sweeteners	sweetener	NNS	O
cyclamate	cyclamate	NN	O
and	and	CC	O
acesulphame	acesulphame	NN	O
.	.	.	O

Among	among	IN	O
top	top	JJ	O
scoring	score	VBG	O
hits	hit	NNS	O
,	,	,	O
10	10	CD	O
structures	structure	NNS	O
were	be	VBD	O
selected	select	VBN	O
for	for	IN	O
biological	biological	JJ	O
evaluation	evaluation	NN	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
candidates	candidate	NNS	O
were	be	VBD	O
tested	test	VBN	O
before	before	RB	O
as	as	IN	O
human	human	JJ	O
CA	CA	NNP	O
II	II	NNP	O
inhibitors	inhibitor	NNS	O
and	and	CC	O
they	-PRON-	PRP	O
showed	show	VBD	O
poor	poor	JJ	O
inhibitory	inhibitory	JJ	O
potency	potency	NN	O
in	in	IN	O
this	this	DT	O
mammalian	mammalian	JJ	O
isoform	isoform	NN	B
.	.	.	O

As	as	IN	O
previously	previously	RB	O
mentioned	mention	VBN	O
,	,	,	O
CA	CA	NNP	O
II	II	NNP	O
is	be	VBZ	O
ubiquitous	ubiquitous	JJ	O
in	in	IN	O
humans	human	NNS	O
and	and	CC	O
it	-PRON-	PRP	O
was	be	VBD	O
considered	consider	VBN	O
as	as	IN	O
an	an	DT	O
anti	anti	JJ	O
-	-	JJ	O
target	target	NN	O
in	in	IN	O
this	this	DT	O
investigation	investigation	NN	O
,	,	,	O
since	since	IN	O
we	-PRON-	PRP	O
are	be	VBP	O
looking	look	VBG	O
for	for	IN	O
selective	selective	JJ	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
the	the	DT	O
parasite	parasite	NN	O
isoform	isoform	NN	O
.	.	.	O

An	an	DT	O
Sx.18Mv	Sx.18Mv	NNP	O
-	-	HYPH	O
R	R	NNP	O
Applied	Applied	NNP	O
Photophysics	Photophysics	NNP	O
Oxford	Oxford	NNP	O
,	,	,	O
UK	UK	NNP	O
stopped	stop	VBD	O
-	-	HYPH	O
flow	flow	NN	O
instrument	instrument	NN	O
has	have	VBZ	O
been	be	VBN	O
used	use	VBN	O
to	to	TO	O
assay	assay	VB	O
the	the	DT	O
catalytic	catalytic	JJ	O
activity	activity	NN	O
of	of	IN	O
various	various	JJ	O
CA	CA	NNP	O
isozymes	isozyme	NNS	O
for	for	IN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
reaction	reaction	NN	B
.	.	.	O

Phenol	Phenol	NNP	O
red	red	JJ	O
at	at	IN	O
a	a	DT	O
concentration	concentration	NN	O
of	of	IN	O
0.2âmM	0.2âmm	NN	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
indicator	indicator	NN	O
,	,	,	O
working	work	VBG	O
at	at	IN	O
the	the	DT	O
absorbance	absorbance	NN	O
maximum	maximum	NN	O
of	of	IN	O
557ânm	557ânm	CD	O
,	,	,	O
with	with	IN	O
10âmM	10âmm	CD	O
Hepes	Hepes	NNPS	O
pH	pH	NNP	O
7.5	7.5	CD	O
as	as	IN	O
buffer	buffer	NN	O
,	,	,	O
0.1âM	0.1âM	NNP	O
Na2SO4	Na2SO4	NNP	O
for	for	IN	O
maintaining	maintain	VBG	O
constant	constant	JJ	O
ionic	ionic	JJ	O
strength	strength	NN	O
,	,	,	O
following	follow	VBG	O
the	the	DT	O
CA	CA	NNP	O
-	-	HYPH	O
catalyzed	catalyze	VBN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
reaction	reaction	NN	O
for	for	IN	O
a	a	DT	O
period	period	NN	O
of	of	IN	O
10âs	10âs	CD	O
at	at	IN	O
25âÂ	25ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

The	the	DT	O
CO2	CO2	NNP	O
concentrations	concentration	NNS	O
ranged	range	VBD	O
from	from	IN	O
1.7	1.7	CD	O
to	to	TO	O
17âmM	17âmm	CD	O
for	for	IN	O
the	the	DT	O
determination	determination	NN	O
of	of	IN	O
the	the	DT	O
kinetic	kinetic	JJ	O
parameters	parameter	NNS	O
and	and	CC	O
inhibition	inhibition	NN	O
constants	constant	NNS	O
.	.	.	O

For	for	IN	O
each	each	DT	O
inhibitor	inhibitor	NN	O
at	at	IN	O
least	least	JJS	O
six	six	CD	O
traces	trace	NNS	O
of	of	IN	O
the	the	DT	O
initial	initial	JJ	O
5â10	5â10	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
reaction	reaction	NN	O
have	have	VBP	O
been	be	VBN	O
used	use	VBN	O
for	for	IN	O
determining	determine	VBG	O
the	the	DT	O
initial	initial	JJ	O
velocity	velocity	NN	O
.	.	.	O

The	the	DT	O
uncatalyzed	uncatalyzed	JJ	O
rates	rate	NNS	O
were	be	VBD	O
determined	determine	VBN	O
in	in	IN	O
the	the	DT	O
same	same	JJ	O
manner	manner	NN	O
and	and	CC	O
subtracted	subtract	VBD	O
from	from	IN	O
the	the	DT	O
total	total	JJ	O
observed	observed	JJ	O
rates	rate	NNS	O
.	.	.	O

Stock	stock	NN	O
solutions	solution	NNS	O
of	of	IN	O
inhibitors	inhibitor	NNS	O
10âmM	10âmm	CD	O
were	be	VBD	O
prepared	prepare	VBN	O
in	in	IN	O
distilled	distil	VBN	O
-	-	HYPH	O
deionised	deionise	VBN	O
water	water	NN	O
and	and	CC	O
dilutions	dilution	NNS	O
up	up	RB	O
to	to	IN	O
1ânM	1ânm	CD	O
were	be	VBD	O
done	do	VBN	O
thereafter	thereafter	RB	O
with	with	IN	O
the	the	DT	O
assay	assay	NN	O
buffer	buffer	NN	O
.	.	.	O

Enzyme	Enzyme	NNS	O
and	and	CC	O
inhibitor	inhibitor	NN	O
solutions	solution	NNS	O
were	be	VBD	O
pre	pre	VBN	O
-	-	VBN	O
incubated	incubate	VBN	O
together	together	RB	O
for	for	IN	O
15âmin	15âmin	NNP	O
standard	standard	JJ	O
assay	assay	NNP	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
prior	prior	RB	O
to	to	IN	O
assay	assay	NNP	O
,	,	,	O
to	to	TO	O
allow	allow	VB	O
for	for	IN	O
the	the	DT	O
formation	formation	NN	O
of	of	IN	O
the	the	DT	O
enzymeâinhibitor	enzymeâinhibitor	NNP	O
complex	complex	NN	O
.	.	.	O

The	the	DT	O
inhibition	inhibition	NN	O
constants	constant	NNS	O
were	be	VBD	O
obtained	obtain	VBN	O
by	by	IN	O
non	non	JJ	O
-	-	JJ	O
linear	linear	JJ	O
least	least	JJS	O
-	-	HYPH	O
squares	square	NNS	O
methods	method	NNS	O
using	use	VBG	O
PRISM	PRISM	NNP	O
3	3	CD	O
and	and	CC	O
the	the	DT	O
ChengâPrusoff	ChengâPrusoff	NNP	O
equation	equation	NN	O
,	,	,	O
as	as	IN	O
reported	report	VBN	O
earlier	early	JJR	B
,	,	,	B
.	.	.	O

All	all	DT	O
CAs	ca	NNS	O
were	be	VBD	O
recombinant	recombinant	JJ	O
proteins	protein	NNS	O
produced	produce	VBN	O
as	as	IN	O
reported	report	VBN	O
earlier	early	RBR	O
by	by	IN	O
our	-PRON-	PRP$	O
group	group	NN	B
.	.	.	O

For	for	IN	O
all	all	DT	O
biological	biological	JJ	O
assays	assay	NNS	O
,	,	,	O
stock	stock	NN	O
and	and	CC	O
working	working	NN	O
solutions	solution	NNS	O
of	of	IN	O
the	the	DT	O
candidate	candidate	NN	O
drugs	drug	NNS	O
were	be	VBD	O
prepared	prepare	VBN	O
using	use	VBG	O
DMSO	DMSO	NNP	O
as	as	IN	O
solvent	solvent	NN	O
and	and	CC	O
all	all	DT	O
conditions	condition	NNS	O
were	be	VBD	O
tested	test	VBN	O
in	in	IN	O
triplicate	triplicate	NN	O
.	.	.	O

Epimastigotes	epimastigote	NNS	O
of	of	IN	O
the	the	DT	O
Y	Y	NNP	O
strain	strain	NN	O
of	of	IN	O
T.	T.	NNP	O
cruzi	cruzi	NNS	O
were	be	VBD	O
cultured	culture	VBN	O
at	at	IN	O
28âÂ	28ââ	CD	O
°	°	,	O
C	C	NNP	O
in	in	IN	O
BHT	BHT	NNP	O
medium	medium	NN	O
supplemented	supplement	VBN	O
with	with	IN	O
20âÎ¼g	20âî¼g	CD	O
/	/	SYM	O
ml	ml	NNP	O
haemin	haemin	NNP	O
,	,	,	O
10	10	CD	O
%	%	NN	O
heat	heat	NN	O
-	-	HYPH	O
inactivated	inactivate	VBN	O
foetal	foetal	JJ	O
bovine	bovine	NN	O
serum	serum	NN	O
FBS	FBS	NNP	O
,	,	,	O
100âÂµg	100ââµg	CD	O
/	/	SYM	O
ml	ml	NNP	O
streptomycin	streptomycin	NNP	O
and	and	CC	O
100âU	100âU	NNP	O
/	/	SYM	O
ml	ml	NNP	O
penicillin	penicillin	NN	O
.	.	.	O

The	the	DT	O
antiproliferative	antiproliferative	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
candidates	candidate	NNS	O
was	be	VBD	O
tested	test	VBN	O
at	at	IN	O
50âÂµM	50ââµm	CD	O
concentration	concentration	NN	O
in	in	IN	O
cultures	culture	NNS	O
initiated	initiate	VBN	O
at	at	IN	O
107	107	CD	O
cells	cell	NNS	O
/	/	SYM	O
ml	ml	NN	O
.	.	.	O

Untreated	untreated	JJ	O
controls	control	NNS	O
were	be	VBD	O
performed	perform	VBN	O
under	under	IN	O
the	the	DT	O
same	same	JJ	O
culture	culture	NN	O
conditions	condition	NNS	O
with	with	IN	O
equal	equal	JJ	O
concentrations	concentration	NNS	O
of	of	IN	O
DMSO	DMSO	NNP	O
as	as	IN	O
for	for	IN	O
candidate	candidate	NN	O
drugs	drug	NNS	O
.	.	.	O

After	after	IN	O
3	3	CD	O
and	and	CC	O
7âd	7âd	CD	O
,	,	,	O
the	the	DT	O
number	number	NN	O
of	of	IN	O
viable	viable	JJ	O
parasites	parasite	NNS	O
was	be	VBD	O
counted	count	VBN	O
using	use	VBG	O
a	a	DT	O
haemocytometer	haemocytometer	NN	O
chamber	chamber	NN	O
under	under	IN	O
light	light	JJ	O
microscope	microscope	NN	O
and	and	CC	O
results	result	NNS	O
were	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
percentage	percentage	NN	O
respect	respect	NN	O
of	of	IN	O
the	the	DT	O
untreated	untreated	JJ	O
controls	control	NNS	B
.	.	.	O

Trypomastigotes	trypomastigote	NNS	O
of	of	IN	O
T.	T.	NNP	O
cruzi	cruzi	NNS	O
were	be	VBD	O
purified	purify	VBN	O
at	at	IN	O
the	the	DT	O
parasitemia	parasitemia	NN	O
peak	peak	NN	O
from	from	IN	O
peripheral	peripheral	JJ	O
blood	blood	NN	O
of	of	IN	O
mice	mouse	NNS	O
infected	infect	VBN	O
with	with	IN	O
the	the	DT	O
RA	RA	NNP	O
strain	strain	NN	O
.	.	.	O

Trypomastigotes	trypomastigote	NNS	O
1âÃâ105	1âãâ105	CD	O
per	per	IN	O
well	well	RB	O
were	be	VBD	O
cultured	culture	VBN	O
in	in	IN	O
a	a	DT	O
96	96	CD	O
well	well	NN	O
-	-	HYPH	O
plate	plate	NN	O
final	final	JJ	O
volume	volume	NN	O
200âÎ¼l	200âî¼l	CD	O
in	in	IN	O
RPMI	RPMI	NNP	O
medium	medium	NN	O
supplemented	supplement	VBD	O
with	with	IN	O
10	10	CD	O
%	%	NN	O
FBS	FBS	NNP	O
at	at	IN	O
37âÂ	37ââ	CD	O
°	°	,	O
C	C	NNP	O
in	in	IN	O
5	5	CD	O
%	%	NN	O
CO2	CO2	NNP	O
atmosphere	atmosphere	NN	O
.	.	.	O

After	after	IN	O
24âh	24âh	CD	O
motile	motile	JJ	O
parasites	parasite	NNS	O
were	be	VBD	O
counted	count	VBN	O
in	in	IN	O
haemocytometer	haemocytometer	NN	O
chamber	chamber	NN	O
under	under	IN	O
the	the	DT	O
light	light	JJ	O
microscope	microscope	NN	B
.	.	.	O

Results	result	NNS	O
were	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
%	%	NN	O
viability	viability	NN	O
of	of	IN	O
trypomastigotes	trypomastigote	NNS	O
respect	respect	NN	O
to	to	TO	O
control	control	NN	O
at	at	IN	O
20âÂµM	20ââµm	CD	O
of	of	IN	O
the	the	DT	O
hits	hit	NNS	O
.	.	.	O

Controls	control	NNS	O
were	be	VBD	O
performed	perform	VBN	O
under	under	IN	O
the	the	DT	O
same	same	JJ	O
culture	culture	NN	O
conditions	condition	NNS	O
with	with	IN	O
equal	equal	JJ	O
concentrations	concentration	NNS	O
of	of	IN	O
DMSO	DMSO	NNP	O
as	as	IN	O
for	for	IN	O
candidate	candidate	NN	O
drugs	drug	NNS	O
.	.	.	O

The	the	DT	O
negative	negative	JJ	O
control	control	NN	O
was	be	VBD	O
cultured	culture	VBN	O
with	with	IN	O
PBS	PBS	NNP	O
and	and	CC	O
the	the	DT	O
positive	positive	JJ	O
control	control	NN	O
was	be	VBD	O
cultured	culture	VBN	O
with	with	IN	O
Benznidazole	Benznidazole	NNP	O
20âÂµM	20ââµm	CD	O
.	.	.	O

The	the	DT	O
animal	animal	NN	O
care	care	NN	O
for	for	IN	O
the	the	DT	O
experimental	experimental	JJ	O
protocols	protocol	NNS	O
was	be	VBD	O
conducted	conduct	VBN	O
in	in	IN	O
accordance	accordance	NN	O
with	with	IN	O
the	the	DT	O
guidelines	guideline	NNS	O
for	for	IN	O
the	the	DT	O
care	care	NN	O
and	and	CC	O
use	use	NN	O
of	of	IN	O
laboratory	laboratory	NN	O
animals	animal	NNS	O
approved	approve	VBN	O
by	by	IN	O
the	the	DT	O
Ethical	Ethical	NNP	O
Committee	Committee	NNP	O
of	of	IN	O
the	the	DT	O
Faculty	Faculty	NNP	O
of	of	IN	O
Medicine	Medicine	NNP	O
of	of	IN	O
the	the	DT	O
University	University	NNP	O
of	of	IN	O
Buenos	Buenos	NNP	O
Aires	Aires	NNP	O
.	.	.	O

TcCA	TcCA	NNP	O
has	have	VBZ	O
been	be	VBN	O
recently	recently	RB	O
cloned	clone	VBN	O
and	and	CC	O
characterised	characterise	VBN	O
by	by	IN	O
Pan	Pan	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	B
As	as	IN	O
mentioned	mention	VBN	O
before	before	RB	O
,	,	,	O
the	the	DT	O
three	three	CD	O
His	-PRON-	PRP$	O
residues	residue	NNS	O
coordinating	coordinate	VBG	O
the	the	DT	O
Zinc	Zinc	NNP	O
ion	ion	NN	O
are	be	VBP	O
conserved	conserve	VBN	O
in	in	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
TcCA	tcca	NN	O
,	,	,	O
with	with	IN	O
the	the	DT	O
fourth	fourth	JJ	O
coordination	coordination	NN	O
position	position	NN	O
occupied	occupy	VBN	O
by	by	IN	O
a	a	DT	O
water	water	NN	O
molecule	molecule	NN	O
or	or	CC	O
by	by	IN	O
a	a	DT	O
hydroxide	hydroxide	NN	O
ion	ion	NN	O
,	,	,	O
depending	depend	VBG	O
on	on	IN	O
the	the	DT	O
pH	ph	NN	O
.	.	.	O

Like	like	IN	O
human	human	JJ	O
CA	CA	NNP	O
II	II	NNP	O
,	,	,	O
TcCA	tcca	NN	O
exerts	exert	NNS	O
a	a	DT	O
high	high	JJ	O
catalytic	catalytic	JJ	O
activity	activity	NN	O
,	,	,	O
and	and	CC	O
the	the	DT	O
gatekeeping	gatekeeping	NN	O
residues	residue	NNS	O
Glu106	glu106	CD	O
and	and	CC	O
Thr199	thr199	CD	O
are	be	VBP	O
well	well	RB	O
conserved	conserve	VBN	B
.	.	.	O

However	however	RB	O
,	,	,	O
the	the	DT	O
proton	proton	NNP	O
shuttle	shuttle	NN	O
His64	His64	NNP	O
is	be	VBZ	O
absent	absent	JJ	O
in	in	IN	O
TcCA	tcca	NN	O
isoform	isoform	NN	O
.	.	.	O

Despite	despite	IN	O
several	several	JJ	O
CA	CA	NNP	O
structures	structure	NNS	O
of	of	IN	O
many	many	JJ	O
organisms	organism	NNS	O
have	have	VBP	O
been	be	VBN	O
crystallised	crystallise	VBN	O
so	so	RB	O
far	far	RB	O
,	,	,	O
there	there	EX	O
is	be	VBZ	O
not	not	RB	O
a	a	DT	O
good	good	JJ	O
template	template	NN	O
to	to	TO	O
perform	perform	VB	O
a	a	DT	O
comparative	comparative	JJ	O
modelling	modelling	NN	O
of	of	IN	O
TcCA	tcca	NN	O
.	.	.	O

There	there	EX	O
are	be	VBP	O
924	924	CD	O
structures	structure	NNS	O
of	of	IN	O
CAs	ca	NNS	O
deposited	deposit	VBN	O
in	in	IN	O
the	the	DT	O
Protein	Protein	NNP	O
Data	Data	NNPS	O
Bank	Bank	NNP	O
PDB	PDB	NNP	O
)	)	-RRB-	B
,	,	,	O
but	but	CC	O
all	all	DT	O
of	of	IN	O
them	-PRON-	PRP	O
have	have	VBP	O
sequence	sequence	NN	O
identities	identity	NNS	O
lower	low	JJR	O
than	than	IN	O
30	30	CD	O
%	%	NN	O
with	with	IN	O
TcCA	tcca	NN	O
.	.	.	O

In	in	IN	O
this	this	DT	O
situation	situation	NN	O
,	,	,	O
the	the	DT	O
combination	combination	NN	O
of	of	IN	O
multiple	multiple	JJ	O
templates	template	NNS	O
generally	generally	RB	O
increases	increase	VBZ	O
the	the	DT	O
quality	quality	NN	O
of	of	IN	O
the	the	DT	O
resultant	resultant	JJ	O
model	model	NN	O
,	,	,	O
but	but	CC	O
only	only	RB	O
when	when	WRB	O
the	the	DT	O
correct	correct	JJ	O
templates	template	NNS	O
are	be	VBP	O
combined	combine	VBN	O
since	since	IN	O
there	there	EX	O
is	be	VBZ	O
a	a	DT	O
trade	trade	NN	O
-	-	HYPH	O
off	off	NN	O
between	between	IN	O
the	the	DT	O
number	number	NN	O
of	of	IN	O
sequences	sequence	NNS	O
included	include	VBN	O
and	and	CC	O
the	the	DT	O
noise	noise	NN	O
introduced	introduce	VBN	O
in	in	IN	O
the	the	DT	O
restraints	restraint	NNS	O
.	.	.	O

One	one	CD	O
possible	possible	JJ	O
approach	approach	NN	O
to	to	TO	O
address	address	VB	O
this	this	DT	O
challenge	challenge	NN	O
was	be	VBD	O
recently	recently	RB	O
proposed	propose	VBN	O
by	by	IN	O
Meier	Meier	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	B
and	and	CC	O
used	use	VBN	O
in	in	IN	O
this	this	DT	O
investigation	investigation	NN	O
.	.	.	O

They	-PRON-	PRP	O
introduced	introduce	VBD	O
a	a	DT	O
modification	modification	NN	O
in	in	IN	O
the	the	DT	O
MODELLER	MODELLER	NNP	O
algorithm	algorithm	NN	O
,	,	,	O
using	use	VBG	O
probability	probability	NN	O
theory	theory	NN	O
to	to	TO	O
combine	combine	VB	O
the	the	DT	O
density	density	NN	O
functions	function	NNS	O
of	of	IN	O
individual	individual	JJ	O
template	template	NN	O
restraints	restraint	NNS	B
.	.	.	O

The	the	DT	O
multiple	multiple	JJ	O
sequence	sequence	NN	O
alignment	alignment	NN	O
is	be	VBZ	O
provided	provide	VBN	O
as	as	IN	O
Supporting	Supporting	NNP	O
Information	Information	NNP	O
Figure	figure	NN	O
S1	S1	NNS	O
,	,	,	O
including	include	VBG	O
the	the	DT	O
PDB	PDB	NNP	O
ID	ID	NNP	O
and	and	CC	O
UNIPROT	UNIPROT	NNP	O
ID	ID	NNP	O
of	of	IN	O
each	each	DT	O
template	template	NN	O
selected	select	VBN	O
.	.	.	O

The	the	DT	O
final	final	JJ	O
model	model	NN	O
is	be	VBZ	O
261	261	CD	O
amino	amino	JJ	O
acids	acid	NNS	O
long	long	RB	O
,	,	,	O
spanning	span	VBG	O
from	from	IN	O
residue	residue	NN	O
56	56	CD	O
to	to	IN	O
316	316	CD	O
of	of	IN	O
the	the	DT	O
target	target	NN	O
sequence	sequence	NN	O
.	.	.	O

The	the	DT	O
structural	structural	JJ	O
quality	quality	NN	O
metrics	metric	NNS	O
are	be	VBP	O
summarised	summarise	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
for	for	IN	O
every	every	DT	O
intermediate	intermediate	JJ	O
structure	structure	NN	O
of	of	IN	O
the	the	DT	O
modelling	modelling	NN	O
pipeline	pipeline	NN	O
,	,	,	O
from	from	IN	O
the	the	DT	O
raw	raw	JJ	O
model	model	NN	O
generated	generate	VBN	O
by	by	IN	O
the	the	DT	O
HHPred	HHPred	NNP	O
server	server	NN	O
to	to	IN	O
the	the	DT	O
refined	refined	JJ	O
MD	MD	NNP	O
snapshot	snapshot	NN	O
selected	select	VBN	O
as	as	IN	O
the	the	DT	O
best	good	JJS	O
TcCA	tcca	JJ	O
model	model	NN	O
for	for	IN	O
docking	docking	NN	O
the	the	DT	O
criteria	criterion	NNS	O
for	for	IN	O
this	this	DT	O
selection	selection	NN	O
was	be	VBD	O
included	include	VBN	O
in	in	IN	O
the	the	DT	O
next	next	JJ	O
section	section	NN	O
.	.	.	O

The	the	DT	O
quality	quality	NN	O
of	of	IN	O
the	the	DT	O
models	model	NNS	O
was	be	VBD	O
estimated	estimate	VBN	O
with	with	IN	O
the	the	DT	O
QMEAN	QMEAN	NNP	O
scoring	score	VBG	O
function	function	NN	O
,	,	,	O
and	and	CC	O
its	-PRON-	PRP$	O
stereochemical	stereochemical	JJ	O
correctness	correctness	NN	O
and	and	CC	O
all	all	DT	O
-	-	HYPH	O
atoms	atom	NNS	O
contacts	contact	NNS	O
were	be	VBD	O
evaluated	evaluate	VBN	O
with	with	IN	O
the	the	DT	O
Molprobity	Molprobity	NNP	O
software	software	NN	O
.	.	.	O

Values	value	NNS	O
of	of	IN	O
the	the	DT	O
parameters	parameter	NNS	O
achieved	achieve	VBN	O
in	in	IN	O
the	the	DT	O
structure	structure	NN	O
quality	quality	NN	O
evaluation	evaluation	NN	O
of	of	IN	O
the	the	DT	O
different	different	JJ	O
models	model	NNS	O
of	of	IN	O
TcCA	tcca	NN	O
.	.	.	O

The	the	DT	O
raw	raw	JJ	O
model	model	NN	O
produced	produce	VBN	O
by	by	IN	O
Modeller	Modeller	NNP	O
shows	show	VBZ	O
the	the	DT	O
poorest	poor	JJS	O
quality	quality	NN	O
,	,	,	O
whereas	whereas	IN	O
RosettÃ	RosettÃ	NNP	O
s	s	NNP	O
refined	refined	JJ	O
model	model	NN	O
of	of	IN	O
the	the	DT	O
best	good	JJS	O
snapshot	snapshot	NN	O
17423_refined	17423_refine	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
is	be	VBZ	O
the	the	DT	O
most	most	RBS	O
correct	correct	JJ	O
in	in	IN	O
both	both	CC	O
geometric	geometric	JJ	O
and	and	CC	O
energetic	energetic	JJ	O
evaluations	evaluation	NNS	O
.	.	.	O

The	the	DT	O
normalised	normalised	JJ	O
QMEAN4	qmean4	NN	O
value	value	NN	O
for	for	IN	O
the	the	DT	O
final	final	JJ	O
model	model	NN	O
is	be	VBZ	O
similar	similar	JJ	O
to	to	IN	O
the	the	DT	O
scores	score	NNS	O
achieved	achieve	VBN	O
in	in	IN	O
high	high	JJ	O
resolution	resolution	NN	O
X	x	NN	O
-	-	NN	O
ray	ray	NN	O
structures	structure	NNS	O
of	of	IN	O
comparable	comparable	JJ	O
size	size	NN	O
,	,	,	O
and	and	CC	O
the	the	DT	O
per	per	IN	O
-	-	HYPH	O
residue	residue	NN	O
energy	energy	NN	O
analysis	analysis	NN	O
shows	show	VBZ	O
that	that	IN	O
the	the	DT	O
problematic	problematic	JJ	O
portions	portion	NNS	O
of	of	IN	O
the	the	DT	O
model	model	NN	O
are	be	VBP	O
beyond	beyond	IN	O
the	the	DT	O
defined	define	VBN	O
docking	docking	NN	O
site	site	NN	O
Figure	figure	NN	O
S2	s2	NN	O
.	.	.	O

Figure	figure	NN	O
2	2	CD	O
shows	show	VBZ	O
the	the	DT	O
overall	overall	JJ	O
architecture	architecture	NN	O
of	of	IN	O
the	the	DT	O
final	final	JJ	O
TcCA	tcca	NN	O
model	model	NN	O
,	,	,	O
which	which	WDT	O
was	be	VBD	O
constructed	construct	VBN	O
based	base	VBN	O
on	on	IN	O
the	the	DT	O
multi	multi	JJ	O
-	-	JJ	O
template	template	JJ	O
strategy	strategy	NN	O
and	and	CC	O
subsequently	subsequently	RB	O
refined	refine	VBN	O
by	by	IN	O
iterative	iterative	JJ	O
Rosetta	Rosetta	NNP	O
-	-	HYPH	O
MD	MD	NNP	O
simulations	simulation	NNS	O
.	.	.	O

Coordinates	coordinate	NNS	O
of	of	IN	O
the	the	DT	O
model	model	NN	O
have	have	VBP	O
been	be	VBN	O
included	include	VBN	O
as	as	IN	O
Supporting	Supporting	NNP	O
Information	Information	NNP	O
.	.	.	O

Final	final	JJ	O
model	model	NN	O
of	of	IN	O
TcCA	tcca	NN	O
achieved	achieve	VBN	O
from	from	IN	O
multi	multi	JJ	O
-	-	JJ	O
template	template	JJ	O
comparative	comparative	JJ	O
modelling	modelling	NN	O
and	and	CC	O
subsequent	subsequent	JJ	O
iterative	iterative	JJ	O
Rosetta	Rosetta	NNP	O
-	-	HYPH	O
MD	MD	NNP	O
refinement	refinement	NN	O
.	.	.	O

Histidine	Histidine	NNP	O
residues	residue	NNS	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
are	be	VBP	O
highlighted	highlight	VBN	O
in	in	IN	O
green	green	NN	O
for	for	IN	O
carbon	carbon	NN	O
atoms	atom	NNS	O
and	and	CC	O
in	in	IN	O
blue	blue	NN	O
for	for	IN	O
nitrogen	nitrogen	NN	O
atoms	atom	NNS	O
.	.	.	O

The	the	DT	O
zinc	zinc	NN	O
ion	ion	NN	O
is	be	VBZ	O
represented	represent	VBN	O
as	as	IN	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
bonded	bonded	JJ	O
sphere	sphere	NN	O
in	in	IN	O
grey	grey	NN	O
.	.	.	O

Once	once	IN	O
we	-PRON-	PRP	O
obtained	obtain	VBD	O
an	an	DT	O
ensemble	ensemble	NN	O
of	of	IN	O
TcCA	tcca	NN	O
models	model	NNS	O
,	,	,	O
the	the	DT	O
next	next	JJ	O
step	step	NN	O
was	be	VBD	O
the	the	DT	O
selection	selection	NN	O
of	of	IN	O
the	the	DT	O
best	good	JJS	O
docking	docking	NN	O
conditions	condition	NNS	O
for	for	IN	O
the	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
.	.	.	O

For	for	IN	O
that	that	DT	O
purpose	purpose	NN	O
,	,	,	O
we	-PRON-	PRP	O
analysed	analyse	VBD	O
the	the	DT	O
ability	ability	NN	O
of	of	IN	O
the	the	DT	O
software	software	NN	O
to	to	TO	O
correlate	correlate	VB	O
the	the	DT	O
docking	docking	NN	O
scores	score	NNS	O
with	with	IN	O
the	the	DT	O
pKI	pki	JJ	O
values	value	NNS	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
of	of	IN	O
the	the	DT	O
validation	validation	NN	O
set	set	VBN	O
.	.	.	O

We	-PRON-	PRP	O
docked	dock	VBD	O
the	the	DT	O
validation	validation	NN	O
set	set	VBN	O
into	into	IN	O
the	the	DT	O
final	final	JJ	O
Rosettaâs	rosettaâs	CD	O
refined	refined	JJ	O
models	model	NNS	O
of	of	IN	O
the	the	DT	O
target	target	NN	O
.	.	.	O

Bootstrap	Bootstrap	NNP	O
sampling	sampling	NN	O
was	be	VBD	O
applied	apply	VBN	O
to	to	IN	O
the	the	DT	O
data	datum	NNS	O
to	to	TO	O
calculate	calculate	VB	O
median	median	JJ	O
values	value	NNS	O
and	and	CC	O
its	-PRON-	PRP$	O
associated	associated	JJ	O
confidence	confidence	NN	O
intervals	interval	NNS	O
to	to	TO	O
compare	compare	VB	O
between	between	IN	O
different	different	JJ	O
models	model	NNS	O
.	.	.	O

The	the	DT	O
lowest	low	JJS	O
energy	energy	NN	O
pose	pose	NN	O
from	from	IN	O
all	all	PDT	O
the	the	DT	O
runs	run	NNS	O
was	be	VBD	O
chosen	choose	VBN	O
as	as	IN	O
the	the	DT	O
binding	bind	VBG	O
mode	mode	NN	O
for	for	IN	O
each	each	DT	O
structure	structure	NN	O
.	.	.	O

Other	other	JJ	O
criteria	criterion	NNS	O
would	would	MD	O
be	be	VB	O
to	to	TO	O
consider	consider	VB	O
the	the	DT	O
lowest	low	JJS	O
energy	energy	NN	O
pose	pose	NN	O
from	from	IN	O
the	the	DT	O
most	most	RBS	O
populated	populated	JJ	O
cluster	cluster	NN	O
,	,	,	O
but	but	CC	O
we	-PRON-	PRP	O
found	find	VBD	O
that	that	IN	O
these	these	DT	O
conformations	conformation	NNS	O
oriented	orient	VBD	O
the	the	DT	O
zinc	zinc	NN	O
-	-	HYPH	O
binding	bind	VBG	O
function	function	NN	O
outside	outside	IN	O
the	the	DT	O
binding	bind	VBG	O
site	site	NN	O
for	for	IN	O
some	some	DT	O
compounds	compound	NNS	O
of	of	IN	O
the	the	DT	O
dataset	dataset	NN	O
.	.	.	O

We	-PRON-	PRP	O
did	do	VBD	O
not	not	RB	O
expect	expect	VB	O
a	a	DT	O
perfect	perfect	JJ	O
correlation	correlation	NN	O
between	between	IN	O
the	the	DT	O
Ki	Ki	NNP	O
values	value	NNS	O
and	and	CC	O
the	the	DT	O
scores	score	NNS	O
due	due	IN	O
to	to	IN	O
the	the	DT	O
known	know	VBN	O
limitations	limitation	NNS	O
of	of	IN	O
docking	docking	NN	O
scoring	score	VBG	O
functions	function	NNS	O
to	to	TO	O
predict	predict	VB	O
absolute	absolute	JJ	O
binding	binding	NN	O
energies	energy	NNS	O
,	,	,	O
especially	especially	RB	O
when	when	WRB	O
using	use	VBG	O
protein	protein	NN	O
models	model	NNS	O
instead	instead	RB	O
of	of	IN	O
crystal	crystal	NN	O
structures	structure	NNS	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
there	there	EX	O
are	be	VBP	O
experimental	experimental	JJ	O
errors	error	NNS	O
and	and	CC	O
biological	biological	JJ	O
variability	variability	NN	O
inherent	inherent	JJ	O
to	to	IN	O
all	all	DT	O
bioactivity	bioactivity	NN	O
data	datum	NNS	O
that	that	WDT	O
impacts	impact	VBZ	O
on	on	IN	O
the	the	DT	O
final	final	JJ	O
correlations	correlation	NNS	O
.	.	.	O

Nevertheless	nevertheless	RB	O
,	,	,	O
these	these	DT	O
metrics	metric	NNS	O
can	can	MD	O
be	be	VB	O
applied	apply	VBN	O
to	to	TO	O
compare	compare	VB	O
between	between	IN	O
different	different	JJ	O
protein	protein	NN	O
/	/	SYM	O
docking	dock	VBG	O
models	model	NNS	O
to	to	TO	O
select	select	VB	O
the	the	DT	O
best	good	JJS	O
one	one	CD	O
under	under	IN	O
different	different	JJ	O
conditions	condition	NNS	O
.	.	.	O

Figure	figure	NN	O
3	3	CD	O
shows	show	VBZ	O
the	the	DT	O
statistical	statistical	JJ	O
parameters	parameter	NNS	O
in	in	IN	O
a	a	DT	O
conditional	conditional	JJ	O
violin	violin	NN	O
plot	plot	NN	O
for	for	IN	O
every	every	DT	O
protein	protein	NN	O
model	model	NN	O
,	,	,	O
considering	consider	VBG	O
Pearsonâs	pearsonâs	CD	O
R	r	NN	O
between	between	IN	O
the	the	DT	O
docking	docking	NN	O
scores	score	NNS	O
and	and	CC	O
the	the	DT	O
pKI	pki	JJ	O
values	value	NNS	O
.	.	.	O

According	accord	VBG	O
to	to	IN	O
the	the	DT	O
results	result	NNS	O
,	,	,	O
we	-PRON-	PRP	O
decided	decide	VBD	O
to	to	TO	O
use	use	VB	O
as	as	IN	O
target	target	NN	O
model	model	NN	O
the	the	DT	O
snapshot	snapshot	NN	O
17423_r	17423_r	CD	O
,	,	,	O
since	since	IN	O
it	-PRON-	PRP	O
achieved	achieve	VBD	O
the	the	DT	O
best	good	JJS	O
correlation	correlation	NN	O
metrics	metric	NNS	O
for	for	IN	O
the	the	DT	O
structures	structure	NNS	O
of	of	IN	O
the	the	DT	O
validation	validation	NN	O
set	set	VBN	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
metrics	metric	NNS	O
calculated	calculate	VBN	O
for	for	IN	O
every	every	DT	O
protein	protein	NN	O
model	model	NN	O
are	be	VBP	O
summarised	summarise	VBN	O
in	in	IN	O
Table	Table	NNP	O
S3	S3	NNP	O
.	.	.	O

Pearsonâs	pearsonâs	CD	O
R	r	NN	O
obtained	obtain	VBN	O
from	from	IN	O
docking	dock	VBG	O
the	the	DT	O
validation	validation	NN	O
set	set	VBN	O
on	on	IN	O
every	every	DT	O
refined	refine	VBN	O
MD	MD	NNP	O
snapshot	snapshot	NN	O
.	.	.	O

The	the	DT	O
white	white	JJ	O
dot	dot	NN	O
represents	represent	VBZ	O
the	the	DT	O
median	median	JJ	O
value	value	NN	O
,	,	,	O
and	and	CC	O
the	the	DT	O
black	black	JJ	O
line	line	NN	O
height	height	NN	O
represents	represent	VBZ	O
the	the	DT	O
distance	distance	NN	O
between	between	IN	O
the	the	DT	O
lower	low	JJR	O
quartile	quartile	NNP	O
Q1	Q1	NNP	O
to	to	IN	O
the	the	DT	O
upper	upper	JJ	O
quartile	quartile	NN	O
Q3	Q3	NNP	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
called	call	VBN	O
the	the	DT	O
interquartile	interquartile	NNP	O
range	range	NN	O
IQR	IQR	NNP	O
.	.	.	O

Violin	Violin	NNP	O
plots	plot	NNS	O
show	show	VBP	O
the	the	DT	O
probability	probability	NN	O
density	density	NN	O
of	of	IN	O
the	the	DT	O
data	datum	NNS	O
at	at	IN	O
different	different	JJ	O
values	value	NNS	O
as	as	IN	O
a	a	DT	O
kernel	kernel	NN	O
density	density	NN	O
estimation	estimation	NN	O
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
ROC	ROC	NNP	O
curves	curve	NNS	O
were	be	VBD	O
constructed	construct	VBN	O
to	to	TO	O
evaluate	evaluate	VB	O
the	the	DT	O
capacity	capacity	NN	O
of	of	IN	O
the	the	DT	O
models	model	NNS	O
to	to	TO	O
discriminate	discriminate	VB	O
known	know	VBN	O
inhibitors	inhibitor	NNS	O
from	from	IN	O
non	non	JJ	O
-	-	NNS	O
inhibitors	inhibitor	NNS	O
.	.	.	O

The	the	DT	O
ROC	ROC	NNP	O
curves	curve	VBZ	O
plot	plot	VBP	O
the	the	DT	O
sensitivity	sensitivity	NN	O
of	of	IN	O
the	the	DT	O
model	model	NN	O
true	true	JJ	O
positive	positive	JJ	O
rate	rate	NN	O
as	as	IN	O
a	a	DT	O
function	function	NN	O
of	of	IN	O
the	the	DT	O
false	false	JJ	O
positive	positive	JJ	O
rate	rate	NN	O
1âââspecificity	1âââspecificity	CD	O
at	at	IN	O
various	various	JJ	O
threshold	threshold	NN	O
settings	setting	NNS	O
.	.	.	O

It	-PRON-	PRP	O
could	could	MD	O
be	be	VB	O
interpreted	interpret	VBN	O
as	as	IN	O
the	the	DT	O
probability	probability	NN	O
that	that	IN	O
a	a	DT	O
classifier	classifier	NN	O
like	like	IN	O
the	the	DT	O
docking	docking	NN	O
score	score	NN	O
ranks	rank	VBZ	O
a	a	DT	O
randomly	randomly	RB	O
chosen	choose	VBN	O
active	active	JJ	O
compound	compound	NN	O
higher	high	JJR	O
than	than	IN	O
a	a	DT	O
randomly	randomly	RB	O
chosen	choose	VBN	O
inactive	inactive	JJ	O
one	one	CD	B
,	,	,	B
.	.	.	O

Accordingly	accordingly	RB	O
,	,	,	O
a	a	DT	O
perfect	perfect	JJ	O
classification	classification	NN	O
of	of	IN	O
compounds	compound	NNS	O
would	would	MD	O
be	be	VB	O
represented	represent	VBN	O
in	in	IN	O
the	the	DT	O
graph	graph	NN	O
by	by	IN	O
a	a	DT	O
line	line	NN	O
that	that	WDT	O
starts	start	VBZ	O
from	from	IN	O
the	the	DT	O
origin	origin	NN	O
,	,	,	O
reaches	reach	VBZ	O
vertically	vertically	RB	O
the	the	DT	O
upper	upper	JJ	O
left	left	JJ	O
corner	corner	NN	O
,	,	,	O
and	and	CC	O
then	then	RB	O
goes	go	VBZ	O
to	to	IN	O
the	the	DT	O
upper	upper	JJ	O
right	right	JJ	O
corner	corner	NN	B
.	.	.	O

The	the	DT	O
area	area	NN	O
under	under	IN	O
the	the	DT	O
curve	curve	NN	O
AUC	AUC	NNP	O
will	will	MD	O
be	be	VB	O
equal	equal	JJ	O
to	to	IN	O
one	one	CD	O
for	for	IN	O
this	this	DT	O
ideal	ideal	JJ	O
performance	performance	NN	O
while	while	IN	O
an	an	DT	O
AUC	AUC	NNP	O
of	of	IN	O
0.5	0.5	CD	O
will	will	MD	O
represent	represent	VB	O
a	a	DT	O
random	random	JJ	O
selection	selection	NN	O
of	of	IN	O
active	active	JJ	O
compounds	compound	NNS	O
.	.	.	O

Figure	figure	NN	O
4	4	CD	O
shows	show	VBZ	O
the	the	DT	O
ROC	ROC	NNP	O
curve	curve	NN	O
obtained	obtain	VBN	O
for	for	IN	O
the	the	DT	O
best	good	JJS	O
docking	docking	NN	O
model	model	NN	O
selected	select	VBN	O
for	for	IN	O
the	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
.	.	.	O

The	the	DT	O
black	black	JJ	O
line	line	NN	O
represents	represent	VBZ	O
a	a	DT	O
random	random	JJ	O
classifier	classifier	NN	O
whose	whose	WP$	O
AUC	AUC	NNP	O
-	-	HYPH	O
ROC	ROC	NNP	O
is	be	VBZ	O
0.5	0.5	CD	O
,	,	,	O
whereas	whereas	IN	O
the	the	DT	O
AUC	AUC	NNP	O
-	-	HYPH	O
ROC	ROC	NNP	O
for	for	IN	O
our	-PRON-	PRP$	O
model	model	NN	O
is	be	VBZ	O
0.915	0.915	CD	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
very	very	RB	O
close	close	JJ	O
to	to	IN	O
the	the	DT	O
optimal	optimal	JJ	O
value	value	NN	O
.	.	.	O

ROC	ROC	NNP	O
curve	curve	NN	O
obtained	obtain	VBN	O
for	for	IN	O
the	the	DT	O
final	final	JJ	O
model	model	NN	O
applied	apply	VBN	O
in	in	IN	O
the	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
.	.	.	O

The	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
of	of	IN	O
our	-PRON-	PRP$	O
database	database	NN	O
with	with	IN	O
the	the	DT	O
refined	refined	JJ	O
model	model	NN	O
17423_r	17423_r	CD	O
identified	identify	VBD	O
42	42	CD	O
structures	structure	NNS	O
as	as	IN	O
possible	possible	JJ	O
TcCA	tcca	NN	O
inhibitors	inhibitor	NNS	O
.	.	.	O

Among	among	IN	O
them	-PRON-	PRP	O
,	,	,	O
10	10	CD	O
compounds	compound	NNS	O
were	be	VBD	O
selected	select	VBN	O
for	for	IN	O
biological	biological	JJ	O
evaluation	evaluation	NN	O
Figure	Figure	NNP	O
5	5	CD	O
.	.	.	O

The	the	DT	O
criteria	criterion	NNS	O
of	of	IN	O
choice	choice	NN	O
were	be	VBD	O
the	the	DT	O
docking	docking	NN	O
scores	score	NNS	O
and	and	CC	O
the	the	DT	O
chemical	chemical	NN	O
structure	structure	NN	O
of	of	IN	O
the	the	DT	O
candidates	candidate	NNS	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
important	important	JJ	O
to	to	TO	O
note	note	VB	O
that	that	IN	O
human	human	JJ	O
examination	examination	NN	O
of	of	IN	O
the	the	DT	O
hits	hit	NNS	O
is	be	VBZ	O
highly	highly	RB	O
recommended	recommend	VBN	O
for	for	IN	O
the	the	DT	O
selection	selection	NN	O
of	of	IN	O
the	the	DT	O
candidates	candidate	NNS	O
,	,	,	O
since	since	IN	O
it	-PRON-	PRP	O
helps	help	VBZ	O
to	to	TO	O
reduce	reduce	VB	O
false	false	JJ	O
positives	positive	NNS	O
due	due	JJ	O
to	to	IN	O
docking	docking	NN	O
score	score	NN	O
artefacts	artefact	NNS	O
and	and	CC	O
can	can	MD	O
lead	lead	VB	O
to	to	IN	O
the	the	DT	O
discovery	discovery	NN	O
of	of	IN	O
more	more	JJR	O
potent	potent	JJ	O
hits	hit	NNS	O
than	than	IN	O
score	score	NN	O
prioritisation	prioritisation	NN	O
alone	alone	RB	O
.	.	.	O

Compounds	compound	NNS	O
1â8	1â8	NNS	O
are	be	VBP	O
aminoester	aminoester	NN	O
-	-	HYPH	O
derived	derive	VBN	O
sulphamides	sulphamide	NNS	O
with	with	IN	O
different	different	JJ	O
substituents	substituent	NNS	O
in	in	IN	O
the	the	DT	O
second	second	JJ	O
nitrogen	nitrogen	NN	O
atom	atom	NN	O
of	of	IN	O
the	the	DT	O
sulphamide	sulphamide	JJ	O
function	function	NN	O
.	.	.	O

These	these	DT	O
compounds	compound	NNS	O
were	be	VBD	O
tested	test	VBN	O
before	before	RB	O
as	as	IN	O
human	human	JJ	O
CA	CA	NNP	O
II	II	NNP	O
inhibitors	inhibitor	NNS	O
,	,	,	O
with	with	IN	O
poor	poor	JJ	O
results	result	NNS	B
.	.	.	O

The	the	DT	O
biological	biological	JJ	O
results	result	NNS	O
against	against	IN	O
TcCA	tcca	NN	O
of	of	IN	O
this	this	DT	O
family	family	NN	O
would	would	MD	O
give	give	VB	O
us	-PRON-	PRP	O
the	the	DT	O
opportunity	opportunity	NN	O
to	to	TO	O
get	get	VB	O
information	information	NN	O
about	about	IN	O
the	the	DT	O
structure	structure	NN	O
-	-	HYPH	O
activity	activity	NN	O
relationships	relationship	NNS	O
.	.	.	O

The	the	DT	O
set	set	NN	O
was	be	VBD	O
completed	complete	VBN	O
with	with	IN	O
two	two	CD	O
artificial	artificial	JJ	O
sweeteners	sweetener	NNS	O
,	,	,	O
acesulphame	acesulphame	NN	O
and	and	CC	O
sodium	sodium	NN	O
cyclamate	cyclamate	NN	O
,	,	,	O
which	which	WDT	O
also	also	RB	O
have	have	VBP	O
low	low	JJ	O
potency	potency	NN	O
as	as	IN	O
human	human	JJ	O
CA	CA	NNP	O
II	II	NNP	O
inhibitors	inhibitor	NNS	O
and	and	CC	O
different	different	JJ	O
scaffolds	scaffold	NNS	O
than	than	IN	O
the	the	DT	O
other	other	JJ	O
selected	select	VBN	O
candidates	candidate	NNS	B
,	,	,	B
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
they	-PRON-	PRP	O
are	be	VBP	O
commercially	commercially	RB	O
available	available	JJ	O
compounds	compound	NNS	O
approved	approve	VBN	O
for	for	IN	O
human	human	JJ	O
consumption	consumption	NN	O
.	.	.	O

Candidates	candidate	NNS	O
selected	select	VBN	O
from	from	IN	O
the	the	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
.	.	.	O

Table	table	NN	O
2	2	CD	O
shows	show	VBZ	O
the	the	DT	O
results	result	NNS	O
of	of	IN	O
the	the	DT	O
biological	biological	JJ	O
assays	assays	RB	O
against	against	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
and	and	CC	O
the	the	DT	O
parasite	parasite	NN	O
.	.	.	O

Inhibition	inhibition	NN	O
values	value	NNS	O
against	against	IN	O
TcCA	TcCA	NNP	O
were	be	VBD	O
reported	report	VBN	O
as	as	IN	O
inhibition	inhibition	NN	O
constants	constant	NNS	O
KI	KI	NNP	O
and	and	CC	O
the	the	DT	O
corresponding	correspond	VBG	O
values	value	NNS	O
against	against	IN	O
human	human	JJ	O
CA	CA	NNP	O
II	II	NNP	O
were	be	VBD	O
also	also	RB	O
included	include	VBN	O
for	for	IN	O
comparison	comparison	NN	O
.	.	.	O

The	the	DT	O
effects	effect	NNS	O
of	of	IN	O
the	the	DT	O
candidates	candidate	NNS	O
with	with	IN	O
respect	respect	NN	O
to	to	IN	O
the	the	DT	O
untreated	untreated	JJ	O
controls	control	NNS	O
against	against	IN	O
T.	T.	NNP	O
cruzi	cruzi	NNS	O
epimastigotes	epimastigote	VBZ	O
Y	y	NN	O
-	-	HYPH	O
strain	strain	NN	O
and	and	CC	O
trypomastigotes	trypomastigote	NNS	O
RA	RA	NNP	O
-	-	HYPH	O
strain	strain	NN	O
were	be	VBD	O
also	also	RB	O
measured	measure	VBN	O
and	and	CC	O
included	include	VBN	O
in	in	IN	O
the	the	DT	O
table	table	NN	O
.	.	.	O

Biological	biological	JJ	O
data	datum	NNS	O
and	and	CC	O
docking	dock	VBG	O
scores	score	NNS	O
achieved	achieve	VBN	O
for	for	IN	O
compounds	compound	NNS	O
of	of	IN	O
the	the	DT	O
set.aInhibition	set.aInhibition	NNP	O
constants	constant	NNS	O
against	against	IN	O
hCAII	hCAII	NNS	O
were	be	VBD	O
taken	take	VBN	O
from	from	IN	O
literature	literature	NN	O
CYTOWANIE.bEpimastigotes	cytowanie.bepimastigote	NNS	O
of	of	IN	O
the	the	DT	O
Y	Y	NNP	O
strain	strain	NN	O
of	of	IN	O
T.	t.	JJ	O
cruzi	cruzi	NNS	O
candidates	candidate	NNS	O
tested	test	VBN	O
at	at	IN	O
50âÂµM).cTrypomastigotes	50ââµm).ctrypomastigotes	CD	O
of	of	IN	O
the	the	DT	O
RA	RA	NNP	O
strain	strain	NN	O
of	of	IN	O
T.	t.	JJ	O
cruzi	cruzi	NNS	O
candidates	candidate	NNS	O
tested	test	VBN	O
at	at	IN	O
20âÂµM	20ââµm	CD	O
.	.	.	O

Regarding	regard	VBG	O
the	the	DT	O
interaction	interaction	NN	O
with	with	IN	O
TcCA	tcca	NN	O
,	,	,	O
most	most	JJS	O
of	of	IN	O
the	the	DT	O
structures	structure	NNS	O
showed	show	VBD	O
interesting	interesting	JJ	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
against	against	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
,	,	,	O
with	with	IN	O
KI	KI	NNP	O
values	value	NNS	O
in	in	IN	O
the	the	DT	O
nanomolar	nanomolar	JJ	O
range	range	NN	O
.	.	.	O

These	these	DT	O
results	result	NNS	O
evidence	evidence	VBP	O
the	the	DT	O
predictive	predictive	JJ	O
capacity	capacity	NN	O
of	of	IN	O
the	the	DT	O
docking	docking	NN	O
model	model	NN	O
to	to	TO	O
identify	identify	VB	O
TcCA	tcca	NN	O
inhibitors	inhibitor	NNS	O
.	.	.	O

Particularly	particularly	RB	O
,	,	,	O
sulphamide	sulphamide	VB	O
5	5	CD	O
is	be	VBZ	O
the	the	DT	O
most	most	RBS	O
potent	potent	JJ	O
inhibitor	inhibitor	NN	O
of	of	IN	O
the	the	DT	O
set	set	NN	O
,	,	,	O
with	with	IN	O
a	a	DT	O
KI	KI	NNP	O
value	value	NN	O
of	of	IN	O
0.26âÎ¼M.	0.26âî¼m.	CD	O
Sodium	Sodium	NNP	O
cyclamate	cyclamate	NN	O
,	,	,	O
a	a	DT	O
widely	widely	RB	O
used	use	VBN	O
sweetener	sweetener	NN	O
,	,	,	O
showed	show	VBD	O
to	to	TO	O
be	be	VB	O
a	a	DT	O
potent	potent	JJ	O
TcCA	tcca	NN	O
inhibitor	inhibitor	NN	O
too	too	RB	O
.	.	.	O

Concerning	concern	VBG	O
selectivity	selectivity	NN	O
,	,	,	O
both	both	DT	O
compounds	compound	NNS	O
are	be	VBP	O
about	about	RB	O
30	30	CD	O
times	time	NNS	O
more	more	RBR	O
active	active	JJ	O
against	against	IN	O
the	the	DT	O
parasite	parasite	NN	O
target	target	NN	O
than	than	IN	O
the	the	DT	O
human	human	JJ	O
CA	CA	NNP	O
II	II	NNP	O
,	,	,	O
which	which	WDT	O
represent	represent	VBP	O
an	an	DT	O
important	important	JJ	O
aspect	aspect	NN	O
to	to	TO	O
be	be	VB	O
considered	consider	VBN	O
in	in	IN	O
future	future	JJ	O
investigations	investigation	NNS	O
.	.	.	O

Figure	figure	NN	O
6	6	CD	O
shows	show	VBZ	O
the	the	DT	O
representation	representation	NN	O
of	of	IN	O
the	the	DT	O
binding	bind	VBG	O
interaction	interaction	NN	O
of	of	IN	O
compound	compound	NNP	O
5	5	CD	O
with	with	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

The	the	DT	O
docking	docking	NN	O
programme	programme	NN	O
orients	orient	VBZ	O
one	one	CD	O
nitrogen	nitrogen	NN	O
atom	atom	NN	O
of	of	IN	O
the	the	DT	O
sulphamide	sulphamide	JJ	O
group	group	NN	O
towards	towards	IN	O
the	the	DT	O
zinc	zinc	NN	O
ion	ion	NN	O
,	,	,	O
whereas	whereas	IN	O
oxygen	oxygen	NN	O
atoms	atom	NNS	O
acts	act	VBZ	O
as	as	IN	O
hydrogen	hydrogen	NNP	O
bond	bond	NN	O
acceptors	acceptor	NNS	O
for	for	IN	O
THR201	THR201	NNP	O
and	and	CC	O
THR202	THR202	NNP	O
sidechain	sidechain	JJ	O
hydroxyl	hydroxyl	NN	O
groups	group	NNS	O
.	.	.	O

Similar	similar	JJ	O
interactions	interaction	NNS	O
were	be	VBD	O
achieved	achieve	VBN	O
between	between	IN	O
the	the	DT	O
second	second	JJ	O
nitrogen	nitrogen	NN	O
atom	atom	NN	O
of	of	IN	O
the	the	DT	O
sulphamide	sulphamide	NN	O
and	and	CC	O
the	the	DT	O
Tyr4	Tyr4	NNP	O
side	side	NN	O
chain	chain	NN	O
.	.	.	O

This	this	DT	O
residue	residue	NN	O
is	be	VBZ	O
also	also	RB	O
involved	involve	VBN	O
in	in	IN	O
positive	positive	JJ	O
aromatic	aromatic	JJ	O
interactions	interaction	NNS	O
with	with	IN	O
the	the	DT	O
inhibitor	inhibitor	NN	O
.	.	.	O

A	a	NN	O
Best	good	JJS	O
docking	docking	NN	O
solution	solution	NN	O
for	for	IN	O
the	the	DT	O
interaction	interaction	NN	O
of	of	IN	O
compound	compound	NNP	O
5	5	CD	O
within	within	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
TcCA	tcca	NN	O
.	.	.	O

Histidine	histidine	NN	O
and	and	CC	O
important	important	JJ	O
residues	residue	NNS	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
are	be	VBP	O
highlighted	highlight	VBN	O
in	in	IN	O
grey	grey	NN	O
for	for	IN	O
carbon	carbon	NN	O
atoms	atom	NNS	O
,	,	,	O
in	in	IN	O
red	red	NN	O
for	for	IN	O
oxygen	oxygen	NN	O
atoms	atom	NNS	O
and	and	CC	O
in	in	IN	O
blue	blue	NN	O
for	for	IN	O
nitrogen	nitrogen	NN	O
atoms	atom	NNS	O
.	.	.	O

The	the	DT	O
zinc	zinc	NN	O
ion	ion	NN	O
is	be	VBZ	O
represented	represent	VBN	O
as	as	IN	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
bonded	bonded	JJ	O
sphere	sphere	NN	O
in	in	IN	O
cyan	cyan	NNP	O
.	.	.	O

Colour	Colour	NNP	O
code	code	NN	O
for	for	IN	O
compound	compound	NN	O
5	5	CD	O
:	:	:	O
Carbon	carbon	NN	O
atoms	atom	NNS	O
in	in	IN	O
green	green	JJ	O
,	,	,	O
Nitrogen	Nitrogen	NNP	O
atoms	atom	NNS	O
in	in	IN	O
blue	blue	NNP	O
,	,	,	O
sulphur	sulphur	NNP	O
atoms	atom	VBZ	O
in	in	IN	O
yellow	yellow	NN	O
and	and	CC	O
oxygen	oxygen	NN	O
atoms	atom	NNS	O
in	in	IN	O
red	red	NN	O
.	.	.	O

B	b	NN	O
Schematic	schematic	JJ	O
representation	representation	NN	O
of	of	IN	O
the	the	DT	O
interactions	interaction	NNS	O
between	between	IN	O
compound	compound	NN	O
5	5	CD	O
and	and	CC	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
the	the	DT	O
TcCA	tcca	NN	O
model	model	NN	O
.	.	.	O

Similarly	similarly	RB	O
,	,	,	O
Figure	figure	NN	O
7	7	CD	O
shows	show	VBZ	O
the	the	DT	O
representation	representation	NN	O
of	of	IN	O
the	the	DT	O
interaction	interaction	NN	O
proposed	propose	VBN	O
by	by	IN	O
docking	docking	NN	O
between	between	IN	O
cyclamate	cyclamate	NN	O
and	and	CC	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
TcCA	tcca	NN	O
.	.	.	O

The	the	DT	O
nitrogen	nitrogen	NN	O
atom	atom	NN	O
of	of	IN	O
the	the	DT	O
sulphamate	sulphamate	NN	O
function	function	NN	O
interacts	interact	VBZ	O
with	with	IN	O
the	the	DT	O
Zinc	Zinc	NNP	O
ion	ion	NN	O
and	and	CC	O
their	-PRON-	PRP$	O
oxygen	oxygen	NN	O
atoms	atom	NNS	O
behave	behave	VBP	O
as	as	IN	O
hydrogen	hydrogen	NN	O
bonding	bonding	NN	O
acceptors	acceptor	NNS	O
from	from	IN	O
the	the	DT	O
Thr	Thr	NNP	O
residues	residue	NNS	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

The	the	DT	O
cyclohexyl	cyclohexyl	NN	O
substituent	substituent	NN	O
attached	attach	VBD	O
to	to	IN	O
the	the	DT	O
N	n	CD	O
atom	atom	NN	O
contributes	contribute	VBZ	O
to	to	IN	O
the	the	DT	O
binding	binding	NN	O
through	through	IN	O
hydrophobic	hydrophobic	JJ	O
interactions	interaction	NNS	O
.	.	.	O

A	a	NN	O
Best	good	JJS	O
docking	docking	NN	O
solution	solution	NN	O
for	for	IN	O
the	the	DT	O
interaction	interaction	NN	O
of	of	IN	O
cyclamate	cyclamate	NN	O
with	with	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
TcCA	tcca	NN	O
.	.	.	O

Histidine	histidine	NN	O
and	and	CC	O
important	important	JJ	O
residues	residue	NNS	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
are	be	VBP	O
highlighted	highlight	VBN	O
in	in	IN	O
grey	grey	NN	O
for	for	IN	O
carbon	carbon	NN	O
atoms	atom	NNS	O
,	,	,	O
in	in	IN	O
red	red	NN	O
for	for	IN	O
oxygen	oxygen	NN	O
atoms	atom	NNS	O
and	and	CC	O
in	in	IN	O
blue	blue	NN	O
for	for	IN	O
nitrogen	nitrogen	NN	O
atoms	atom	NNS	O
.	.	.	O

The	the	DT	O
zinc	zinc	NN	O
ion	ion	NN	O
is	be	VBZ	O
represented	represent	VBN	O
as	as	IN	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
bonded	bonded	JJ	O
sphere	sphere	NN	O
in	in	IN	O
cyan	cyan	NNP	O
.	.	.	O

Colour	Colour	NNP	O
code	code	NN	O
for	for	IN	O
cyclamate	cyclamate	NN	O
:	:	:	O
Carbon	carbon	NN	O
atoms	atom	NNS	O
in	in	IN	O
violet	violet	NN	O
,	,	,	O
Nitrogen	Nitrogen	NNP	O
atoms	atom	NNS	O
in	in	IN	O
blue	blue	NNP	O
,	,	,	O
sulphur	sulphur	NNP	O
atoms	atom	VBZ	O
in	in	IN	O
yellow	yellow	NN	O
and	and	CC	O
oxygen	oxygen	NN	O
atoms	atom	NNS	O
in	in	IN	O
red	red	NN	O
.	.	.	O

B	b	NN	O
Schematic	schematic	JJ	O
representation	representation	NN	O
of	of	IN	O
the	the	DT	O
interactions	interaction	NNS	O
between	between	IN	O
cyclamate	cyclamate	NN	O
and	and	CC	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
the	the	DT	O
TcCA	tcca	NN	O
model	model	NN	O
.	.	.	O

The	the	DT	O
effect	effect	NN	O
of	of	IN	O
the	the	DT	O
candidates	candidate	NNS	O
against	against	IN	O
T.	T.	NNP	O
cruzi	cruzi	NNS	O
epimastigotes	epimastigote	NNS	O
,	,	,	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
infective	infective	JJ	O
and	and	CC	O
proliferative	proliferative	JJ	O
stage	stage	NN	O
,	,	,	O
was	be	VBD	O
tested	test	VBN	O
at	at	IN	O
50âÂµM	50ââµm	CD	O
Table	table	NN	O
2	2	CD	O
.	.	.	O

Among	among	IN	O
the	the	DT	O
best	good	JJS	O
two	two	CD	O
TcCA	tcca	NN	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
the	the	DT	O
set	set	NN	O
,	,	,	O
sodium	sodium	NN	O
cyclamate	cyclamate	NN	O
showed	show	VBD	O
20	20	CD	O
%	%	NN	O
of	of	IN	O
inhibition	inhibition	NN	O
on	on	IN	O
the	the	DT	O
proliferation	proliferation	NN	O
of	of	IN	O
epimastigotes	epimastigote	NNS	O
at	at	IN	O
the	the	DT	O
tested	test	VBN	O
concentration	concentration	NN	O
7th	7th	JJ	O
day	day	NN	O
.	.	.	O

When	when	WRB	O
sodium	sodium	NN	O
cyclamate	cyclamate	NN	O
was	be	VBD	O
tested	test	VBN	O
against	against	IN	O
trypomastigote	trypomastigote	NNP	O
,	,	,	O
one	one	CD	O
of	of	IN	O
the	the	DT	O
clinically	clinically	RB	O
relevant	relevant	JJ	O
stages	stage	NNS	O
of	of	IN	O
T.	t.	NN	O
cruzi	cruzi	NNS	O
,	,	,	O
this	this	DT	O
candidate	candidate	NN	O
inhibited	inhibit	VBD	O
parasite	parasite	NN	O
viability	viability	NN	O
by	by	IN	O
50	50	CD	O
%	%	NN	O
at	at	IN	O
20âÂµM.	20ââµm.	CD	O
Other	other	JJ	O
compounds	compound	NNS	O
also	also	RB	O
showed	show	VBD	O
good	good	JJ	O
inhibition	inhibition	NN	O
profiles	profile	NNS	O
against	against	IN	O
both	both	DT	O
forms	form	NNS	O
of	of	IN	O
the	the	DT	O
parasite	parasite	NN	O
,	,	,	O
but	but	CC	O
they	-PRON-	PRP	O
were	be	VBD	O
poorer	poor	JJR	O
TcCA	tcca	NN	O
inhibitors	inhibitor	NNS	O
.	.	.	O

The	the	DT	O
lack	lack	NN	O
of	of	IN	O
correlation	correlation	NN	O
between	between	IN	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
effects	effect	NNS	O
on	on	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
and	and	CC	O
the	the	DT	O
trypanocidal	trypanocidal	JJ	O
effects	effect	NNS	O
on	on	IN	O
the	the	DT	O
parasite	parasite	NN	O
may	may	MD	O
suggest	suggest	VB	O
that	that	IN	O
other	other	JJ	O
mechanisms	mechanism	NNS	O
of	of	IN	O
action	action	NN	O
besides	besides	IN	O
CA	CA	NNP	O
inhibition	inhibition	NN	O
are	be	VBP	O
present	present	JJ	O
.	.	.	O

Other	other	JJ	O
possible	possible	JJ	O
explanations	explanation	NNS	O
to	to	IN	O
the	the	DT	O
discrepancy	discrepancy	NN	O
may	may	MD	O
relate	relate	VB	O
with	with	IN	O
the	the	DT	O
drugs	drug	NNS	O
uptake	uptake	VBP	O
kinetics	kinetic	NNS	O
by	by	IN	O
the	the	DT	O
parasite	parasite	NN	O
and/or	and/or	CC	O
biotransformation	biotransformation	NN	O
/	/	SYM	O
inactivation	inactivation	NN	O
of	of	IN	O
the	the	DT	O
candidates	candidate	NNS	O
.	.	.	O

We	-PRON-	PRP	O
report	report	VBP	O
the	the	DT	O
results	result	NNS	O
of	of	IN	O
a	a	DT	O
target	target	NN	O
-	-	HYPH	O
based	base	VBN	O
virtual	virtual	JJ	O
screening	screening	NN	O
for	for	IN	O
the	the	DT	O
discovery	discovery	NN	O
of	of	IN	O
new	new	JJ	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
TcCA	tcca	NN	O
with	with	IN	O
poor	poor	JJ	O
interaction	interaction	NN	O
with	with	IN	O
hCA	hca	CD	O
II	II	NNP	O
.	.	.	O

As	as	IN	O
the	the	DT	O
experimental	experimental	JJ	O
structure	structure	NN	O
of	of	IN	O
the	the	DT	O
target	target	NN	O
is	be	VBZ	O
not	not	RB	O
available	available	JJ	O
,	,	,	O
we	-PRON-	PRP	O
turned	turn	VBD	O
to	to	IN	O
the	the	DT	O
careful	careful	JJ	O
construction	construction	NN	O
of	of	IN	O
multi	multi	JJ	O
-	-	JJ	O
template	template	JJ	O
three	three	CD	O
-	-	HYPH	O
dimensional	dimensional	JJ	O
models	model	NNS	O
,	,	,	O
to	to	TO	O
select	select	VB	O
the	the	DT	O
best	good	JJS	O
macrostructure	macrostructure	NN	O
for	for	IN	O
docking	docking	NN	O
simulation	simulation	NN	O
.	.	.	O

The	the	DT	O
iterative	iterative	JJ	O
combination	combination	NN	O
of	of	IN	O
Rosetta	Rosetta	NNP	O
and	and	CC	O
MD	MD	NNP	O
simulations	simulation	NNS	O
allowed	allow	VBD	O
us	-PRON-	PRP	O
to	to	TO	O
significantly	significantly	RB	O
improve	improve	VB	O
the	the	DT	O
quality	quality	NN	O
of	of	IN	O
the	the	DT	O
starting	starting	NN	O
model	model	NN	O
,	,	,	O
as	as	IN	O
reflected	reflect	VBN	O
by	by	IN	O
the	the	DT	O
reported	report	VBN	O
metrics	metric	NNS	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
important	important	JJ	O
to	to	TO	O
note	note	VB	O
that	that	IN	O
we	-PRON-	PRP	O
have	have	VBP	O
achieved	achieve	VBN	O
target	target	NN	O
models	model	NNS	O
with	with	IN	O
high	high	JJ	O
quality	quality	NN	O
despite	despite	IN	O
the	the	DT	O
low	low	JJ	O
sequence	sequence	NN	O
identity	identity	NN	O
of	of	IN	O
the	the	DT	O
templates	template	NNS	O
found	find	VBN	O
for	for	IN	O
their	-PRON-	PRP$	O
construction	construction	NN	O
.	.	.	O

The	the	DT	O
docking	docking	NN	O
calculations	calculation	NNS	O
were	be	VBD	O
fully	fully	RB	O
validated	validate	VBN	O
through	through	IN	O
a	a	DT	O
test	test	NN	O
set	set	NN	O
of	of	IN	O
compounds	compound	NNS	O
with	with	IN	O
reported	reported	JJ	O
activity	activity	NN	O
against	against	IN	O
TcCA	tcca	NN	O
,	,	,	O
which	which	WDT	O
led	lead	VBD	O
us	-PRON-	PRP	O
to	to	TO	O
find	find	VB	O
a	a	DT	O
structural	structural	JJ	O
model	model	NN	O
with	with	IN	O
the	the	DT	O
best	good	JJS	O
scoring	score	VBG	O
power	power	NN	O
.	.	.	O

By	by	IN	O
the	the	DT	O
application	application	NN	O
of	of	IN	O
the	the	DT	O
model	model	NN	O
in	in	IN	O
a	a	DT	O
virtual	virtual	JJ	O
screening	screening	NN	O
campaign	campaign	NN	O
we	-PRON-	PRP	O
identified	identify	VBD	O
sulphamides	sulphamide	NNS	O
with	with	IN	O
high	high	JJ	O
potency	potency	NN	O
and	and	CC	O
selectivity	selectivity	NN	O
against	against	IN	O
the	the	DT	O
ubiquitous	ubiquitous	JJ	O
human	human	JJ	O
CAII	CAII	NNP	O
isoform	isoform	NN	O
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
the	the	DT	O
model	model	NN	O
selected	select	VBD	O
two	two	CD	O
commercial	commercial	JJ	O
and	and	CC	O
widely	widely	RB	O
used	use	VBN	O
artificial	artificial	JJ	O
sweeteners	sweetener	NNS	O
with	with	IN	O
abundant	abundant	JJ	O
toxicological	toxicological	JJ	O
data	datum	NNS	O
available	available	JJ	O
.	.	.	O

They	-PRON-	PRP	O
share	share	VBP	O
the	the	DT	O
sulphamate	sulphamate	NN	O
function	function	NN	O
,	,	,	O
a	a	DT	O
bioisosteric	bioisosteric	JJ	O
partner	partner	NN	O
of	of	IN	O
sulphamide	sulphamide	NN	O
as	as	IN	O
zinc	zinc	NN	O
-	-	HYPH	O
binding	bind	VBG	O
function	function	NN	O
.	.	.	O

The	the	DT	O
assays	assay	NNS	O
in	in	IN	O
parasites	parasite	NNS	O
identified	identify	VBN	O
sodium	sodium	NN	O
cyclamate	cyclamate	NN	O
as	as	IN	O
the	the	DT	O
most	most	RBS	O
promising	promising	JJ	O
structure	structure	NN	O
in	in	IN	O
terms	term	NNS	O
of	of	IN	O
trypanocidal	trypanocidal	JJ	O
activity	activity	NN	O
,	,	,	O
reducing	reduce	VBG	O
trypomastigote	trypomastigote	JJ	O
viability	viability	NN	O
by	by	IN	O
48	48	CD	O
%	%	NN	O
at	at	IN	O
20âÂµM.	20ââµm.	CD	O
Further	further	JJ	O
molecular	molecular	JJ	O
modelling	modelling	NN	O
and	and	CC	O
SAR	SAR	NNP	O
studies	study	NNS	O
will	will	MD	O
be	be	VB	O
performed	perform	VBN	O
in	in	IN	O
future	future	JJ	O
investigations	investigation	NNS	O
,	,	,	O
to	to	TO	O
achieve	achieve	VB	O
a	a	DT	O
deeper	deep	JJR	O
knowledge	knowledge	NN	O
about	about	IN	O
the	the	DT	O
molecular	molecular	JJ	O
determinants	determinant	NNS	O
of	of	IN	O
the	the	DT	O
potency	potency	NN	O
and	and	CC	O
selectivity	selectivity	NN	O
against	against	IN	O
TcCA	tcca	NN	O
.	.	.	O

